<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en"><?DTDIdentifier.IdentifierValue article.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName article.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName bmc2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Pain</journal-id><journal-id journal-id-type="iso-abbrev">Mol Pain</journal-id><journal-title-group><journal-title>Molecular Pain</journal-title></journal-title-group><issn pub-type="epub">1744-8069</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3640958</article-id><article-id pub-id-type="publisher-id">1744-8069-9-21</article-id><article-id pub-id-type="pmid">23597049</article-id><article-id pub-id-type="doi">10.1186/1744-8069-9-21</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Peripheral nerve injury is accompanied by chronic transcriptome-wide changes in the mouse prefrontal cortex</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="A1"><name><surname>Alvarado</surname><given-names>Sebastian</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>sebastian.alvarado@mail.mcgill.ca</email></contrib><contrib contrib-type="author" equal-contrib="yes" id="A2"><name><surname>Tajerian</surname><given-names>Maral</given-names></name><xref ref-type="aff" rid="I3">3</xref><xref ref-type="aff" rid="I4">4</xref><email>maral.tajerian@mail.mcgill.ca</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Millecamps</surname><given-names>Magali</given-names></name><xref ref-type="aff" rid="I4">4</xref><xref ref-type="aff" rid="I5">5</xref><email>magali.millecamps@mcgill.ca</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Suderman</surname><given-names>Mathew</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>msuder@mcb.mcgill.ca</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Stone</surname><given-names>Laura S</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I3">3</xref><xref ref-type="aff" rid="I4">4</xref><xref ref-type="aff" rid="I5">5</xref><xref ref-type="aff" rid="I6">6</xref><email>laura.s.stone@mcgill.ca</email></contrib><contrib contrib-type="author" corresp="yes" id="A6"><name><surname>Szyf</surname><given-names>Moshe</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>moshe.szyf@mcgill.ca</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Pharmacology and Therapeutics, McGill University, Faculty of Medicine, 3655 Promenade Sir William Osler, Montr&#x000e9;al, Qu&#x000e9;bec H3G 1Y6, Canada</aff><aff id="I2"><label>2</label>Sackler Program for Epigenetics &#x00026; Developmental Psychobiology, McGill University, 3655 Promenade Sir William Osler, Montr&#x000e9;al, Qu&#x000e9;bec H3G 1Y6, Canada</aff><aff id="I3"><label>3</label>Department of Neurology and Neurosurgery, McGill University, Faculty of Medicine, 3801 University Street, Montreal, Quebec H3A 2B4, Canada</aff><aff id="I4"><label>4</label>Alan Edwards Centre for Research on Pain, McGill University, 740 Dr. Penfield Avenue, Montreal, Quebec H3A 1A4, Canada</aff><aff id="I5"><label>5</label>Faculty of Dentistry, McGill University, 3640 University Street, Montreal, Quebec H3A 2B2, Canada</aff><aff id="I6"><label>6</label>Department of Anesthesiology, Anesthesia Research Unit, McGill University, Faculty of Medicine, 3655 Promenade Sir William Osler, Montreal, Quebec H3G 1Y6, Canada</aff><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>18</day><month>4</month><year>2013</year></pub-date><volume>9</volume><fpage>21</fpage><lpage>21</lpage><history><date date-type="received"><day>3</day><month>12</month><year>2012</year></date><date date-type="accepted"><day>22</day><month>3</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013 Alvarado et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Alvarado et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.molecularpain.com/content/9/1/21"/><abstract><sec><title>Background</title><p>Peripheral nerve injury can have long-term consequences including pain-related manifestations, such as hypersensitivity to cutaneous stimuli, as well as affective and cognitive disturbances, suggesting the involvement of supraspinal mechanisms. Changes in brain structure and cortical function associated with many chronic pain conditions have been reported in the prefrontal cortex (PFC). The PFC is implicated in pain-related co-morbidities such as depression, anxiety and impaired emotional decision-making ability. We recently reported that this region is subject to significant epigenetic reprogramming following peripheral nerve injury, and normalization of pain-related structural, functional and epigenetic abnormalities in the PFC are all associated with effective pain reduction.</p><p>In this study, we used the Spared Nerve Injury (SNI) model of neuropathic pain to test the hypothesis that peripheral nerve injury triggers persistent long-lasting changes in gene expression in the PFC, which alter functional gene networks, thus providing a possible explanation for chronic pain associated behaviors.</p></sec><sec><title>Results</title><p>SNI or sham surgery where performed in male CD1 mice at three months of age. Six months after injury, we performed transcriptome-wide sequencing (RNAseq), which revealed 1147 differentially regulated transcripts in the PFC in nerve-injured vs. control mice. Changes in gene expression occurred across a number of functional gene clusters encoding cardinal biological processes as revealed by Ingenuity Pathway Analysis. Significantly altered biological processes included neurological disease, skeletal muscular disorders, behavior, and psychological disorders. Several of the changes detected by RNAseq were validated by RT-QPCR and included transcripts with known roles in chronic pain and/or neuronal plasticity including the NMDA receptor (glutamate receptor, ionotropic, NMDA; <italic>grin1</italic>)<italic>,</italic> neurite outgrowth <italic>(</italic>roundabout 3<italic>; robo3),</italic> gliosis <italic>(</italic>glial fibrillary acidic protein<italic>; gfap),</italic> vesicular release (synaptotagmin 2<italic>; syt2),</italic> and neuronal excitability <italic>(</italic>voltage-gated sodium channel, type I<italic>; scn1a)</italic>.</p></sec><sec><title>Conclusions</title><p>This study used an unbiased approach to document long-term alterations in gene expression in the brain following peripheral nerve injury. We propose that these changes are maintained as a memory of an insult that is temporally and spatially distant from the initial injury.</p></sec></abstract><kwd-group><kwd>Neuropathic pain</kwd><kwd>Chronic pain</kwd><kwd>RNA sequencing</kwd><kwd>Transcriptome</kwd><kwd>Noncoding RNA</kwd><kwd>Neuronal plasticity</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>Peripheral nerve injury can result in a multitude of changes within an organism, including motor dysfunction, pain and associated cognitive and emotional comorbidities. While acute pain related to an injury is protective and normally resolves, chronic pain can be detrimental to the overall wellbeing and functioning of the individual. Indeed, occasionally the &#x0201c;memory&#x0201d; of injury, in the form of chronic pain, persists long after the initial recovery phase and becomes difficult to reverse. This is due, in part, to changes in anatomy and function that take place in the peripheral as well as the central nervous system. These changes can occur at many levels: individual molecules, synapses, cellular function, and network activity [<xref ref-type="bibr" rid="B1">1</xref>]. It is therefore not surprising that injury is often accompanied by local or systemic alterations in gene expression. To date, several reports have identified strong links between injury and transcriptional changes in the peripheral nervous system [<xref ref-type="bibr" rid="B2">2</xref>], blood [<xref ref-type="bibr" rid="B3">3</xref>] and in the brain [<xref ref-type="bibr" rid="B4">4</xref>]. However, the full profile of transcriptional changes that accompany chronic pain in response to peripheral injury is unknown.</p><p>The fact that peripheral injury results in chronic behavioral changes suggests that transient exposure to injury is chronically embedded in the transcription programming within the central nervous system, resulting in altered phenotypic behaviors. In the current study, we tested this hypothesis by focusing on the transcriptional changes that occur in the prefrontal cortex (PFC) of chronically neuropathic mice six months after the induction of neuropathy. This area was chosen based on evidence indicating its involvement in pain modulation [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>] and epigenetic differences that accompany peripheral nerve injury [<xref ref-type="bibr" rid="B7">7</xref>]. In humans with back pain, reversible pathological changes in both cortical thickness and functional activation have been shown in the PFC [<xref ref-type="bibr" rid="B8">8</xref>]. In animal models of neuropathic pain, the PFC undergoes synaptic re-organization as early as 8 days following nerve injury [<xref ref-type="bibr" rid="B9">9</xref>], and shows reductions in grey matter 5 months post-injury [<xref ref-type="bibr" rid="B10">10</xref>]. Since the PFC has also been implicated in depression and anxiety [<xref ref-type="bibr" rid="B11">11</xref>], common co-morbidities of chronic pain, transcriptional changes in brain regions such as the PFC can also provide an explanation for these co-morbidities.</p><p>While brain-specific transcription associated with neuropathic pain and injury has been previously investigated, few studies have looked at the effects at time points longer than ~ 1 month post-injury, whereas individual patients often suffer for many years following the initial injury. This distinction is critical as the development of co-morbid conditions, such as anxiety-like behavior in the rat, takes multiple months to develop [<xref ref-type="bibr" rid="B10">10</xref>]. Thus, early time points might not fully incorporate the impact of long term chronic pain on CNS plasticity. Furthermore, previous studies have been limited by microarray-based technologies that are inherently biased by probe density/design and limited to coding mRNA transcripts [<xref ref-type="bibr" rid="B12">12</xref>]. We therefore investigated the long-term (6 months post-injury) transcriptional changes induced by peripheral injury in the prefrontal cortex using whole transcriptome sequencing (RNAseq) in a mouse model of chronic pain (Spared Nerve Injury, SNI). Furthermore, we employed bioinformatic tools to identify functional gene clusters that were altered in the prefrontal cortex.</p><p>The aim of this work is to provide a comprehensive and unbiased look at the molecular correlates of peripheral nerve injury and catalog long-term transcriptional changes that may play a role in the pathologies associated with injury and pain. We believe that our findings will help shed light on the &#x0201c;signature&#x0201d; of painful neuropathy in the brain at both the molecular and network levels.</p></sec><sec sec-type="results"><title>Results</title><sec><title>Peripheral injury is accompanied by behavioral signs of neuropathic pain six months post-injury</title><p>The persistence of nerve injury-induced hypersensitivity to mechanical and cold stimuli and injury-related motor impairment were confirmed six months following SNI (data not shown; mechanical thresholds (grams) = 0.20&#x000b1;0.05 in SNI vs 0.82&#x000b1;0.07 in controls, p&#x0003c;0.0001; acetone-evoked behaviors (seconds) = 2.9&#x000b1;0.4 vs. 0.4&#x000b1;0.05 in controls, p&#x0003e;0.0001; motor impairment (latency to fall from accelerating rotarod) = 76&#x000b1;11 in SNI vs. 225&#x000b1;21 in controls, p&#x0003e;0.0001; n=10/group).</p></sec><sec><title>Peripheral injury is accompanied transcriptomic changes in the prefrontal cortex six months post-injury</title><p>Six months following SNI, significant changes in the expression levels of 1147 different transcripts were identified in the prefrontal cortex (Figure&#x02009;<xref ref-type="fig" rid="F1">1</xref>, Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>: Table S1). Considering the genomic base pair representation of exonic (3.2%), intronic (35.5%) and intergenic (61.3%) elements in mouse (Figure&#x02009;<xref ref-type="fig" rid="F1">1</xref>A), the PFC SNI-associated transcriptome was equally partitioned between coding RNA accounting for 40% (exonic) and 60% non-coding (intergenic+intronic) base pairs of the transcriptome (Figure&#x02009;<xref ref-type="fig" rid="F1">1</xref>B). Within differentially expressed transcripts in SNI vs. sham control animals, the largest transcriptional changes were observed in protein-coding exons (63.4%) with the rest made up of non-coding RNA. Within non-coding RNAs, the largest observed changes were in non-translated transcripts (retained introns and processed transcripts) followed by classes of microRNAs, transcribed processed pseudogenes, lincRNAs and nonsense mediated decay (Figure&#x02009;<xref ref-type="fig" rid="F1">1</xref>C).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Direction and nature of transcriptome expression alterations in the prefrontal cortex six months after injury in SNI and Sham animals.</bold> (<bold>A</bold>) Distribution of exonic, intergenic and intronic elements within the mouse genome. (<bold>B</bold>) Distribution of transcribed exonic, intergenic and intronic elements in SNI PFC transcriptome relative to Sham PFC. (<bold>C</bold>) Distribution of differentially expressed RNAs in the PFC associated with peripheral nerve injury.</p></caption><graphic xlink:href="1744-8069-9-21-1"/></fig><p>The transcripts with the largest log<sub>2</sub>fold changes in RNA expression in response to SNI (summarized in Table&#x02009;<xref ref-type="table" rid="T1">1</xref>) included several transcripts with previously uncharacterized roles in the brain. Within this subset, specific transcripts with a role in subcellular structure (<italic>actbl</italic>, <italic>col11a2</italic>, <italic>krt12</italic>, <italic>krt20</italic>) and development pathways <italic>(lrat</italic>[<xref ref-type="bibr" rid="B13">13</xref>], <italic>aldh3a1</italic>[<xref ref-type="bibr" rid="B14">14</xref>], <italic>crb1</italic>[<xref ref-type="bibr" rid="B15">15</xref>]) show some of the greatest transcriptional changes. These transcripts showed large transcriptional differences from control ranging between 4.20 and 5.20 log<sub>2</sub>fold change for repressed genes and between 2.61 and 5.60 log<sub>2</sub>fold for induced genes.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Top upregulated and downregulated transcripts in SNI</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><th align="center"><bold>Gene</bold></th><th align="center"><bold>Chr</bold></th><th align="center"><bold>Start</bold></th><th align="center"><bold>End</bold></th><th align="center"><bold>p-Value</bold></th><th align="center"><bold>Log</bold><sub><bold>2</bold></sub><bold>fold change</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom"><bold>Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1</bold><hr/></td><td align="center" valign="bottom"><bold>5</bold><hr/></td><td align="right" valign="bottom">145036642<hr/></td><td align="right" valign="bottom">145036834<hr/></td><td align="right" valign="bottom">1.23E-08<hr/></td><td align="center" valign="bottom"><bold>&#x02212;5.20</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>A330050B17Rik</bold><hr/></td><td align="center" valign="bottom"><bold>3</bold><hr/></td><td align="right" valign="bottom">35921194<hr/></td><td align="right" valign="bottom">35924028<hr/></td><td align="right" valign="bottom">5.37E-07<hr/></td><td align="center" valign="bottom"><bold>&#x02212;4.92</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Actin, beta-like 2</bold><hr/></td><td align="center" valign="bottom"><bold>13</bold><hr/></td><td align="right" valign="bottom">112045221<hr/></td><td align="right" valign="bottom">112047957<hr/></td><td align="right" valign="bottom">8.12E-10<hr/></td><td align="center" valign="bottom"><bold>&#x02212;4.56</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>mmu-mir-220</bold><hr/></td><td align="center" valign="bottom"><bold>6</bold><hr/></td><td align="right" valign="bottom">136348946<hr/></td><td align="right" valign="bottom">136349031<hr/></td><td align="right" valign="bottom">5.54E-20<hr/></td><td align="center" valign="bottom"><bold>&#x02212;4.53</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Crumbs homolog 1</bold><hr/></td><td align="center" valign="bottom"><bold>1</bold><hr/></td><td align="right" valign="bottom">141142194<hr/></td><td align="right" valign="bottom">141145652<hr/></td><td align="right" valign="bottom">4.49E-5<hr/></td><td align="center" valign="bottom"><bold>&#x02212;4.43</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Collagen, type XI, alpha 2</bold><hr/></td><td align="center" valign="bottom"><bold>17</bold><hr/></td><td align="right" valign="bottom">34189110<hr/></td><td align="right" valign="bottom">34189163<hr/></td><td align="right" valign="bottom">2.34E-4<hr/></td><td align="center" valign="bottom"><bold>&#x02212;4.23</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Thyrotropin-releasing hormone receptor</bold><hr/></td><td align="center" valign="bottom"><bold>15</bold><hr/></td><td align="right" valign="bottom">44065008<hr/></td><td align="right" valign="bottom">44065236<hr/></td><td align="right" valign="bottom">2.34E-4<hr/></td><td align="center" valign="bottom"><bold>&#x02212;4.22</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Gm14204</bold><hr/></td><td align="center" valign="bottom"><bold>2</bold><hr/></td><td align="right" valign="bottom">158421208<hr/></td><td align="right" valign="bottom">158422248<hr/></td><td align="right" valign="bottom">1.10E-12<hr/></td><td align="center" valign="bottom"><bold>&#x02212;4.08</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Gap junction alpha-5</bold><hr/></td><td align="center" valign="bottom"><bold>3</bold><hr/></td><td align="right" valign="bottom">96879570<hr/></td><td align="right" valign="bottom">96881339<hr/></td><td align="right" valign="bottom">2.37E-11<hr/></td><td align="center" valign="bottom"><bold>5.60</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Keratin 20*</bold><hr/></td><td align="center" valign="bottom"><bold>11</bold><hr/></td><td align="right" valign="bottom">99299001<hr/></td><td align="right" valign="bottom">99299464<hr/></td><td align="right" valign="bottom">7.97E-6<hr/></td><td align="center" valign="bottom"><bold>4.65</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Mediator complex subunit 23</bold><hr/></td><td align="center" valign="bottom"><bold>10</bold><hr/></td><td align="right" valign="bottom">24589792<hr/></td><td align="right" valign="bottom">24589952<hr/></td><td align="right" valign="bottom">4.30E-4<hr/></td><td align="center" valign="bottom"><bold>4.08</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Keratin 12</bold><hr/></td><td align="center" valign="bottom"><bold>11</bold><hr/></td><td align="right" valign="bottom">99280858<hr/></td><td align="right" valign="bottom">99281014<hr/></td><td align="right" valign="bottom">3.83E-10<hr/></td><td align="center" valign="bottom"><bold>4.08</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>40S ribosomal protein S28</bold><hr/></td><td align="center" valign="bottom"><bold>17</bold><hr/></td><td align="right" valign="bottom">33959981<hr/></td><td align="right" valign="bottom">33960061<hr/></td><td align="right" valign="bottom">1.47E-13<hr/></td><td align="center" valign="bottom"><bold>3.76</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>A830036E02Rik</bold><hr/></td><td align="center" valign="bottom"><bold>11</bold><hr/></td><td align="right" valign="bottom">99283179<hr/></td><td align="right" valign="bottom">99283574<hr/></td><td align="right" valign="bottom">1.77E-17<hr/></td><td align="center" valign="bottom"><bold>3.69</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Lecithin-retinol acyltransferase</bold><hr/></td><td align="center" valign="bottom"><bold>3</bold><hr/></td><td align="right" valign="bottom">82696501<hr/></td><td align="right" valign="bottom">82701050<hr/></td><td align="right" valign="bottom">4.22E-08<hr/></td><td align="center" valign="bottom"><bold>3.10</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Thiosulfate sulfurtransferase (rhodanese)-like domain containing 2</bold><hr/></td><td align="center" valign="bottom"><bold>4</bold><hr/></td><td align="right" valign="bottom">46151364<hr/></td><td align="right" valign="bottom">46151566<hr/></td><td align="right" valign="bottom">5.24E-4<hr/></td><td align="center" valign="bottom"><bold>2.77</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Complement component 1 r subcomponent A</bold><hr/></td><td align="center" valign="bottom"><bold>6</bold><hr/></td><td align="right" valign="bottom">124463670<hr/></td><td align="right" valign="bottom">124463895<hr/></td><td align="right" valign="bottom">5.24E-4<hr/></td><td align="center" valign="bottom"><bold>2.73</bold><hr/></td></tr><tr><td align="left"><bold>Aldehyde dehydrogenase 3 family member A1</bold></td><td align="center"><bold>11</bold></td><td align="right">61028052</td><td align="right">61028260</td><td align="right">3.22E-6</td><td align="center"><bold>2.61</bold></td></tr></tbody></table><table-wrap-foot><p>Changes are labeled as log<sub>2</sub>fold change.</p></table-wrap-foot></table-wrap><p>We further classified differentially expressed transcripts in SNI animals that have brain-specific functions (Summarized in Table&#x02009;<xref ref-type="table" rid="T2">2</xref>). Examples include down-regulation of neurotransmitter channel and receptor subunits <italic>gabrg1/3, clca1, slc14a1</italic> and <italic>drd2</italic> and the astrocyte marker <italic>gfap</italic> while sodium channel subunit <italic>scn1a</italic>, NMDA subunit <italic>grin1</italic>, and promoters of neuronal growth <italic>xlr4b, robo3, prc</italic>, and <italic>cux1</italic> were all up-regulated in PFC from injured mice. Specific transcripts identified with asterisks in Tables&#x02009;<xref ref-type="table" rid="T1">1</xref> and <xref ref-type="table" rid="T2">2</xref> were further validated with RT-qPCR (labeled with asterisks) and summarized in Figures&#x02009;<xref ref-type="fig" rid="F2">2</xref>A-D, <xref ref-type="fig" rid="F3">3</xref>B-C, <xref ref-type="fig" rid="F4">4</xref>B-C and <xref ref-type="fig" rid="F5">5</xref>B. Within these validated genes, <italic>robo3, scn1a, grin1, xlr4b, krt20, syt2,</italic> and <italic>lbp</italic> showed marked induction following SNI while <italic>gfap</italic> and <italic>clca1</italic> showed marked repression (unpaired 2-tailed t-test, p&#x0003c;0.05, n=8). Whereas the genes in Figure&#x02009;<xref ref-type="fig" rid="F2">2</xref> were selected for validation due to an interesting role in the CNS, Figures&#x02009;<xref ref-type="fig" rid="F4">4</xref>, <xref ref-type="fig" rid="F5">5</xref>, and <xref ref-type="fig" rid="F6">6</xref> highlight validated genes within the context of an identified functional gene cluster.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Biased upregulated and downregulated transcripts in SNI with known brain-specific functions</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><th align="center"><bold>Gene</bold></th><th align="center"><bold>Chr</bold></th><th align="center"><bold>Start</bold></th><th align="center"><bold>End</bold></th><th align="center"><bold>p-Value</bold></th><th align="center"><bold>Log</bold><sub><bold>2</bold></sub><bold>fold change</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom"><bold>Calcium-activated chloride channel regulator 1*</bold><hr/></td><td align="center" valign="bottom"><bold>3</bold><hr/></td><td align="right" valign="bottom">144409728<hr/></td><td align="right" valign="bottom">144409992<hr/></td><td align="right" valign="bottom">4.95E-04<hr/></td><td align="center" valign="bottom"><bold>&#x02212;3.19</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Solute carrier family 14 (urea transporter), member 1</bold><hr/></td><td align="center" valign="bottom"><bold>18</bold><hr/></td><td align="right" valign="bottom">78308093<hr/></td><td align="right" valign="bottom">78308285<hr/></td><td align="right" valign="bottom">2.90E-06<hr/></td><td align="center" valign="bottom"><bold>&#x02212;2.37</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Gamma-aminobutyric acid receptor subunit gamma-1</bold><hr/></td><td align="center" valign="bottom"><bold>5</bold><hr/></td><td align="right" valign="bottom">71185885<hr/></td><td align="right" valign="bottom">71185952<hr/></td><td align="right" valign="bottom">8.90E-05<hr/></td><td align="center" valign="bottom"><bold>&#x02212;2.17</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Activating transcription factor 3</bold><hr/></td><td align="center" valign="bottom"><bold>1</bold><hr/></td><td align="right" valign="bottom">192994175<hr/></td><td align="right" valign="bottom">192995558<hr/></td><td align="right" valign="bottom">8.97E-07<hr/></td><td align="center" valign="bottom"><bold>&#x02212;1.98</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Fatty acid binding protein 7</bold><hr/></td><td align="center" valign="bottom"><bold>10</bold><hr/></td><td align="right" valign="bottom">57505312<hr/></td><td align="right" valign="bottom">57505484<hr/></td><td align="right" valign="bottom">4.36E-12<hr/></td><td align="center" valign="bottom"><bold>&#x02212;1.44</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Gamma-aminobutyric acid receptor subunit gamma-3</bold><hr/></td><td align="center" valign="bottom"><bold>7</bold><hr/></td><td align="right" valign="bottom">64433752<hr/></td><td align="right" valign="bottom">64435107<hr/></td><td align="right" valign="bottom">3.29E-04<hr/></td><td align="center" valign="bottom"><bold>&#x02212;1.38</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Glial fibrillary acidic protein *</bold><hr/></td><td align="center" valign="bottom"><bold>11</bold><hr/></td><td align="right" valign="bottom">102753225<hr/></td><td align="right" valign="bottom">102753268<hr/></td><td align="right" valign="bottom">2.40E-04<hr/></td><td align="center" valign="bottom"><bold>&#x02212;1.24</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Fos</bold><hr/></td><td align="center" valign="bottom"><bold>12</bold><hr/></td><td align="right" valign="bottom">86816542<hr/></td><td align="right" valign="bottom">86816649<hr/></td><td align="right" valign="bottom">4.62E-04<hr/></td><td align="center" valign="bottom"><bold>&#x02212;0.90</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Dopamine receptor D2</bold><hr/></td><td align="center" valign="bottom"><bold>9</bold><hr/></td><td align="right" valign="bottom">49215006<hr/></td><td align="right" valign="bottom">49216282<hr/></td><td align="right" valign="bottom">1.44E-05<hr/></td><td align="center" valign="bottom"><bold>&#x02212;0.88</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>X-linked lymphocyte-regulated 4B *</bold><hr/></td><td align="center" valign="bottom"><bold>X</bold><hr/></td><td align="right" valign="bottom">70463702<hr/></td><td align="right" valign="bottom">70467280<hr/></td><td align="right" valign="bottom">1.72E-03<hr/></td><td align="center" valign="bottom"><bold>3.87</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Lipopolysaccharide-binding protein*</bold><hr/></td><td align="center" valign="bottom"><bold>2</bold><hr/></td><td align="right" valign="bottom">158139209<hr/></td><td align="right" valign="bottom">158139364<hr/></td><td align="right" valign="bottom">3.31E-04<hr/></td><td align="center" valign="bottom"><bold>2.54</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Protein regulator of cytokinesis 1</bold><hr/></td><td align="center" valign="bottom"><bold>7</bold><hr/></td><td align="right" valign="bottom">87460000<hr/></td><td align="right" valign="bottom">87461144<hr/></td><td align="right" valign="bottom">5.70E-05<hr/></td><td align="center" valign="bottom"><bold>2.40</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Cut-like homeobox 1</bold><hr/></td><td align="center" valign="bottom"><bold>5</bold><hr/></td><td align="right" valign="bottom">137041250<hr/></td><td align="right" valign="bottom">137041567<hr/></td><td align="right" valign="bottom">1.46E-04<hr/></td><td align="center" valign="bottom"><bold>2.24</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Roundabout, axon guidance receptor, homolog 3*</bold><hr/></td><td align="center" valign="bottom"><bold>9</bold><hr/></td><td align="right" valign="bottom">37227254<hr/></td><td align="right" valign="bottom">37227393<hr/></td><td align="right" valign="bottom">1.51E-05<hr/></td><td align="center" valign="bottom"><bold>1.96</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Sodium channel, voltage-gated, type I, alpha subunit*</bold><hr/></td><td align="center" valign="bottom"><bold>2</bold><hr/></td><td align="right" valign="bottom">66166462<hr/></td><td align="right" valign="bottom">66166603<hr/></td><td align="right" valign="bottom">4.34E-04<hr/></td><td align="center" valign="bottom"><bold>1.10</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Synaptotagmin-2*</bold><hr/></td><td align="center" valign="bottom"><bold>1</bold><hr/></td><td align="right" valign="bottom">136644052<hr/></td><td align="right" valign="bottom">136649726<hr/></td><td align="right" valign="bottom">9.10E-09<hr/></td><td align="center" valign="bottom"><bold>0.91</bold><hr/></td></tr><tr><td align="left" valign="bottom"><bold>Synapsin 1</bold><hr/></td><td align="center" valign="bottom"><bold>X</bold><hr/></td><td align="right" valign="bottom">20497539<hr/></td><td align="right" valign="bottom">20498130<hr/></td><td align="right" valign="bottom">1.72E-03<hr/></td><td align="center" valign="bottom"><bold>0.59</bold><hr/></td></tr><tr><td align="left"><bold>Glutamate [NMDA] receptor subunit zeta-1*</bold></td><td align="center"><bold>2</bold></td><td align="right">25174149</td><td align="right">25174615</td><td align="right">3.31E-04</td><td align="center"><bold>0.57</bold></td></tr></tbody></table><table-wrap-foot><p>Changes are labeled as a log<sub>2</sub>fold change.</p></table-wrap-foot></table-wrap><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>Validation of transcript mRNA expression.</bold> Quantitative PCR validation of downregulated transcripts CLCA1 (<bold>A</bold>) and GFAP (<bold>B</bold>) and upregulated transcripts XLR4B (<bold>C</bold>) and KRT20 (<bold>D</bold>) relative to GAPDH. *=p&#x0003c;0.05. n=8/group. Error bars = S.E.M.</p></caption><graphic xlink:href="1744-8069-9-21-2"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>Functional pathway analysis.</bold> Nerve injury affects transcriptional programs unique to neurological disease, skeletal and muscular disorders, psychological disorders and changes in behavior scored and ranked according to Ingenuity Pathway Analysis using Fisher&#x02019;s exact test. The dotted line indicates the threshold value of p&#x0003c;0.05.</p></caption><graphic xlink:href="1744-8069-9-21-3"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><p><bold>Cellular growth and differentiation.</bold> Nerve injury results in distinct changes in transcription in pathways involved in cellular growth and proliferation. (<bold>A</bold>) RNAseq and IPA identified interacting networks affecting cell cycle, cell proliferation and cellular development. Up-regulated transcripts are marked with red while downregulated transcripts are marked in blue. SYT2 (<bold>B</bold>) SCN1A (<bold>C</bold>) transcripts were validated by qPCR. *=p&#x0003c;0.05. n=8/group. Error bars = S.E.M.</p></caption><graphic xlink:href="1744-8069-9-21-4"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><p><bold>Cell cycle and growth.</bold> SNI causes distinct changes in transcription in pathways involved in cell cycle and growth. (<bold>A</bold>) RNA sequencing and IPA identified interacting networks affecting cell cycle, cellular growth and proliferation and cellular development. Upregulated transcripts are marked with red while downregulated transcripts are marked in blue. ROBO3 (<bold>B</bold>) and KRT20 (<bold>C</bold>) transcripts were validated by qPCR. *=p&#x0003c;0.05. n=8/group. Error bars = S.E.M.</p></caption><graphic xlink:href="1744-8069-9-21-5"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><p><bold>Neuronal development.</bold> SNI causes distinct changes in transcription in pathways involved neuronal development. (<bold>A</bold>) RNA sequencing and IPA identified interacting networks affecting cellular assembly and organization and nervous system development and function. Upregulated transcripts are marked with red while downregulated transcripts are marked in blue. (<bold>B</bold>) GRIN1 transcript was validated by qPCR. *=p&#x0003c;0.05. n=8/group. Error bars = S.E.M.</p></caption><graphic xlink:href="1744-8069-9-21-6"/></fig></sec><sec><title>Peripheral nerve injury results in changed brain-specific transcriptional programs</title><p>Ingenuity Pathway Analysis (IPA) identified specific networks that were dysregulated six months post-SNI in the prefrontal cortex. Biological functions with a cutoff p-value &#x0003c; 0.05 were considered statistically significant. We identified the following biological functions specific to peripheral nerve injury: neurological disease (p-value= 2.02E-21-1.46E-02), behavior (p-value= 2.68E-12-1.31E-02), psychological disorder (p-value=7.80E-11- 1.46E-02), protein synthesis (p-value=1.70E-10 to 4.23E-03), and nervous system development and function (p-value=5.93E-10 to 1.42E-02) (Figure&#x02009;<xref ref-type="fig" rid="F6">6</xref>, Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>: Table S2). In our screen, genetic disorders and skeletal muscular disorders emerged but due to an unclear role in CNS we did not perform further validation within these pathways.</p><p>With each biological function comprised of hundreds of functional gene clusters we then focused on transcriptional clusters previously associated with neurological function. Within this scope, peripheral injury resulted in up-regulation of pathways involved in cellular growth and proliferation (Figure&#x02009;<xref ref-type="fig" rid="F3">3</xref>A), molecular transport and neurological disease (Figure&#x02009;<xref ref-type="fig" rid="F4">4</xref>A) and neuronal development (Figure&#x02009;<xref ref-type="fig" rid="F5">5</xref>A). We validated the induction of representative genes included in these clusters by QRT-PCR: <italic>robo3</italic> and <italic>krt20</italic> in the cellular growth and proliferation pathway (Figure&#x02009;<xref ref-type="fig" rid="F3">3</xref>B-C), <italic>scn1a</italic> and <italic>syt2</italic> in the molecular transport and neurological disease pathway (Figure&#x02009;<xref ref-type="fig" rid="F4">4</xref>B-C) and <italic>grin1</italic> in the neuronal development pathway (Figure&#x02009;<xref ref-type="fig" rid="F5">5</xref>B).</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Our results delineate for the first time a transcriptomic signature in the prefrontal cortex resulting from peripheral injury six months prior. Interestingly, both coding and non-coding transcripts are altered.</p><p>The coding transcripts include both genes that were previously implicated in the pathology associated with neuronal plasticity as well as genes with yet an unknown role in brain function, neuronal plasticity or in chronic pain. We further mapped the functional gene pathways whose transcription was altered, identified specific clusters involved in neuronal plasticity and validated candidate genes within these pathways. Genes known to play a role in brain structure and function that were differentially expressed and validated in response to peripheral injury were: <italic>clca1</italic>, <italic>syt2, grin1, scn1a, krt20, xlr4b, gfap, lbp</italic> and <italic>robo3</italic>. Considering the importance of the PFC to chronic pain and its associated co-morbidities, these broad, functionally-relevant changes in the transcriptome of the PFC provides a possible substrate for the long-term systemic effects of peripheral injury and may elucidate transcriptional mechanisms of supraspinal pathologies associated with chronic pain.</p><sec><title>Coding/noncoding transcriptomic changes</title><p>While annotated coding transcripts account for about a third (n=209000) of the long-term differential transcriptome in response to SNI, the remaining differentially-expressed transcripts were non-coding unannotated RNA (intergenic+intronic) (n=435000) (Figure&#x02009;<xref ref-type="fig" rid="F1">1</xref>B). Within differential exonic transcripts, we further classified all annotated genes into their respective RNA classes (Figure&#x02009;<xref ref-type="fig" rid="F1">1</xref>C). Approximately 60% of exonic elements represent protein-coding genes and the remaining 40% demonstrate a wide array of noncoding RNA with a previously uncharacterized role in peripheral nerve injury (Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>: Table S1). The role of noncoding RNA has been discussed extensively [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>] and it is known to be involved in a variety of functions ranging from translation [<xref ref-type="bibr" rid="B18">18</xref>], splicing [<xref ref-type="bibr" rid="B19">19</xref>] to transcriptional regulation [<xref ref-type="bibr" rid="B20">20</xref>]. The fact that SNI induces non-coding (both annotated and un-annotated) transcripts in the brain that could be detected long after the initial injury suggests that they might be playing a functional role in the brain response to peripheral injury. However, the mechanisms involved remain unknown at this stage. Nevertheless, our data provide further support to the emerging idea that genome-function in the brain involves more than the commonly studied protein coding gene sequences.</p><p>Annotated SNI-associated transcriptional differences were categorized into biological functions using ingenuity pathway analysis and we identified statistically significant affected gene pathways pertinent to neurological disease, behavior and psychological disorders (Figure&#x02009;<xref ref-type="fig" rid="F6">6</xref> Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>: Table S2). The SNI-associated transcriptome of the PFC appears particularly relevant to several of the co-morbidities associated with peripheral nerve injury such as poor sleep, anxiety and depression [<xref ref-type="bibr" rid="B21">21</xref>] as the PFC is highly implicated in these conditions [<xref ref-type="bibr" rid="B22">22</xref>-<xref ref-type="bibr" rid="B24">24</xref>]. Considering the identified molecular pathways (Figure&#x02009;<xref ref-type="fig" rid="F6">6</xref>), chronic neuropathic pain may alter higher order biological functions that may mediate these behavioral disorders.</p></sec><sec><title>Genes involved in chronic injury and altered neuronal growth and proliferation in the PFC</title><p>The up-regulation of <italic>robo3, krt20, xlr4b</italic> in response to peripheral injury and overall pathway analysis suggests altered regulation of gene networks involved in neuronal cellular growth (Figures&#x02009;<xref ref-type="fig" rid="F2">2</xref> &#x00026;<xref ref-type="fig" rid="F3">3</xref>, Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>: Table S2). Previous work using the same model of peripheral nerve injury reported altered neuronal growth in injured animals characterized by longer basal dendrites with more branches in cortical layer 2/3 pyramidal neurons in injured vs. control animals [<xref ref-type="bibr" rid="B9">9</xref>]. The cell adhesion membrane protein ROBO3, which is up-regulated in the injured mice, has been shown to be essential for axonal guidance in drosophila [<xref ref-type="bibr" rid="B25">25</xref>] and is a regulator of cortical interneuron growth in mice [<xref ref-type="bibr" rid="B26">26</xref>] and serotonergic neuronal differentiation [<xref ref-type="bibr" rid="B27">27</xref>]. While not previously considered in the context of peripheral injury, its role in regulating morphology and function of neurons is consistent with a possible contribution to cortical remodeling in response to injury (Figure&#x02009;<xref ref-type="fig" rid="F3">3</xref>B).</p><p><italic>xlr4b</italic>, a non-coding RNA, has been shown to regulate chromatin remodeling as well as modulate cognitive defects in a mouse model of Turner&#x02019;s Syndrome [<xref ref-type="bibr" rid="B28">28</xref>]. Upstream regulators of <italic>xlr4b</italic>, <italic>cux1</italic> and <italic>cux2</italic> control the number and maturity of dendritic spines in cortical neurons in cortical layer 2/3 pyramidal neurons [<xref ref-type="bibr" rid="B29">29</xref>]. Interestingly, in addition to <italic>xlr4b, cux1</italic> is up-regulated (4 fold) in the SNI animals, supporting the hypothesis that this gene regulatory pathway is activated (Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>: Table S1 and Figure&#x02009;<xref ref-type="fig" rid="F3">3</xref>A). <italic>clca1,</italic> which is down-regulated in the PFC in response to peripheral nerve injury (Figure&#x02009;<xref ref-type="fig" rid="F2">2</xref>A), encodes a calcium chloride channel. Calcium chloride channels are highly conserved structurally but have diverse expression patterns and physiological functions [<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B31">31</xref>]. CLCA1 has been implicated in neuronal death [<xref ref-type="bibr" rid="B32">32</xref>], suggesting that CLCA1 might play role in neuronal reorganization in the PFC.</p><p>Lastly, while <italic>krt20</italic> is not directly implicated in neuronal growth, as a soft keratin and intermediary filament, its expression is ubiquitous. <italic>krt20</italic> is up-regulated in the PFC (Figure&#x02009;<xref ref-type="fig" rid="F3">3</xref>C) in response to peripheral nerve injury and it is considered a member of functional pathways involved in cell cycle and proliferation (IPA analysis). Taken together, these data are consistent with alterations in regulation of cell growth and proliferation as a chronic response to peripheral nerve injury. However, direct experiments need to test whether these transcriptional changes in the PFC are causally involved in altering neuronal or associated cell growth in the PFC.</p></sec><sec><title>Molecular transport and neurological disease</title><p>Chronic pain changes the brain at various levels: changes in cortical grey matter [<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B34">34</xref>], white matter [<xref ref-type="bibr" rid="B35">35</xref>], and overall cortical excitability [<xref ref-type="bibr" rid="B36">36</xref>] have all been reported. Recent studies have shown that chronic pain is linked to changes in synaptic structure and function in the primary somatosensory cortex [<xref ref-type="bibr" rid="B37">37</xref>], hippocampus [<xref ref-type="bibr" rid="B38">38</xref>], and anterior cingulate cortex [<xref ref-type="bibr" rid="B39">39</xref>]. It is therefore not surprising that several neurological disorders are co-morbid with chronic pain. Previous reports have shown chronic pain is associated with impaired decision-making [<xref ref-type="bibr" rid="B40">40</xref>], anxiety, depression and sleep disorders [<xref ref-type="bibr" rid="B41">41</xref>]. In the SNI model, the PFC exhibits signs of damage following peripheral injury [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>]. Considering that the PFC is shown to regulate higher order emotional processing, transcriptional changes in the PFC can identify putative candidates mediating known co-morbid pathologies seen with chronic injury and/or pain.</p><p>Mutations in sodium channels have been previously implicated in pain and in the modulation of neuropathic and inflammatory pain [<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B43">43</xref>]. In the present study, IPA-identified pathways reveal that the gene encoding sodium channel <italic>scn1a,</italic> which is a member of the neurological disease functional gene cluster, is up-regulated in the SNI group (Figure&#x02009;<xref ref-type="fig" rid="F4">4</xref>C). Familial missense mutations in <italic>scn1a</italic> have been linked to epilepsy [<xref ref-type="bibr" rid="B44">44</xref>], migraines [<xref ref-type="bibr" rid="B45">45</xref>] and brain structure in aging individuals [<xref ref-type="bibr" rid="B46">46</xref>]. Interestingly, these familial missense mutations can result in increased sodium channel activity; for example, the D188V mutation (linked to epilepsy) results in impaired inactivation, and the Q1489K mutation (linked to familial hemiplegic migraine) results in changes in channel gating which include accelerated recovery from inactivation and increased persistent current [<xref ref-type="bibr" rid="B47">47</xref>]. Thus, the functional result of these missense mutations may be analogous to the impact of nerve injury-induced up-regulation of the same channel.</p><p>This is the first demonstration of long-term overexpression of <italic>scn1a</italic> in the prefrontal cortex following peripheral injury. Nevertheless our data is consistent with previous reports showing up-regulation of SCN3A, for example, in dorsal root ganglia following axotomy [<xref ref-type="bibr" rid="B48">48</xref>]. The data is consistent with the hypothesis that <italic>scn1a</italic> over-expression (and to a lesser degree <italic>scn1b, scn2b</italic>, and <italic>scn4b</italic> (Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>: Table S1)) is involved in increased cortical excitability [<xref ref-type="bibr" rid="B49">49</xref>] associated with chronic pain.</p><p><italic>Synaptotagmin II</italic> (<italic>syt2</italic>) is up-regulated in our model in response to peripheral injury (Figure&#x02009;<xref ref-type="fig" rid="F3">3</xref>B) which is consistent with its role in neurological function and disease. Synatoptoagmins are Ca2+ sensors involved in vesicular trafficking and exocytosis and mediate vesicular release important for neurotransmission [<xref ref-type="bibr" rid="B50">50</xref>]. Syt2 was previously reported to be involved in vesicular GABAergic transmission [<xref ref-type="bibr" rid="B51">51</xref>], and may therefore also be involved in pain-mediated alterations in GABA and glutamate receptor activation known to accompany models of peripheral injury [<xref ref-type="bibr" rid="B52">52</xref>].</p><p>LBP, a mediator of innate immunity [<xref ref-type="bibr" rid="B53">53</xref>], is up-regulated in the PFC of animals with peripheral nerve injury. Interestingly, LBP-KO mice show increased spine density and abnormal spine morphology, indicating a role for LBP role in synaptic pruning [<xref ref-type="bibr" rid="B54">54</xref>]. We speculate that its role in TLR4 signaling may link it to the neuroinflammation and depression induced by treatment with lipopolysaccharide [<xref ref-type="bibr" rid="B55">55</xref>]. Altered LBP expression in the PFC in response to SNI might be playing similar roles in the gene networks, possibly mediating cortical neuroinflammation in animals with peripheral nerve injury.</p></sec><sec><title>Nervous system development and function</title><p>One of the functional gene pathways that is highly enriched by genes that are differentially expressed six months after nerve injury is the pathway involved in nervous system development and functions (Figure&#x02009;<xref ref-type="fig" rid="F5">5</xref>, Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>: Table S2). One member of this cluster which is up-regulated by SNI is <italic>grin1</italic> (NMDA receptor subunit 1). NMDA receptors are linked to neuroplastic changes including long-term potentiation [<xref ref-type="bibr" rid="B56">56</xref>] and implicated in psychiatric disorders [<xref ref-type="bibr" rid="B57">57</xref>-<xref ref-type="bibr" rid="B59">59</xref>] and anxiety [<xref ref-type="bibr" rid="B60">60</xref>,<xref ref-type="bibr" rid="B61">61</xref>].</p><p>Within the nervous system development and function cluster we found a marked decrease in the expression of <italic>gfap</italic>, a marker for astrocytes. Astrocytes are implicated in synapse maintenance, secretion of neurotrophins, and overall function in maintaining neuroplasticity. Previous work has shown that peripheral nerve injury is associated with increased levels of <italic>gfap</italic> in the spinal and medullary dorsal horns [<xref ref-type="bibr" rid="B62">62</xref>,<xref ref-type="bibr" rid="B63">63</xref>], anterior cingulate cortex [<xref ref-type="bibr" rid="B64">64</xref>-<xref ref-type="bibr" rid="B66">66</xref>], and the periaqueductal gray, during early and intermediate time points after injury [<xref ref-type="bibr" rid="B65">65</xref>]. However, there is evidence showing <italic>gfap</italic> is down-regulated in the PFC in psychological disorders [<xref ref-type="bibr" rid="B67">67</xref>,<xref ref-type="bibr" rid="B68">68</xref>]. Furthermore, pain-related pathological changes in neuroinflammation in the spinal cord, such as microglial activation, may occur in the absence of parallel dysregulation in supraspinal structures [<xref ref-type="bibr" rid="B69">69</xref>], and glial activation following spinal cord injury is both spatially and temporally regulated. Thus, the well documented increases in astroctye activation in the spinal cord following nerve injury [<xref ref-type="bibr" rid="B70">70</xref>] may not be mirrored in the PFC and/or <italic>gfap</italic> could be up-regulated during the early and middle stages of injury but down-regulated at very chronic stages once the co-morbidities have appeared.</p></sec></sec><sec sec-type="conclusions"><title>Conclusions</title><p>We demonstrate broad changes in gene expression in the mouse prefrontal cortex six months after peripheral nerve injury, illustrating a long-term impact of a peripheral injury on brain genome function. The use of RNAseq allowed for an unbiased picture of the transcriptomic changes involved in chronic neuropathy in the PFC. Furthermore, the ingenuity pathway analysis revealed functional gene networks that were significantly implicated including networks involved in brain development and function. These reported changes and their functional analysis will generate hypotheses on the molecular mechanisms that mediate chronic pain and its co-morbidities that will need to be tested in future experiments.</p><p>These wide-spread changes in gene expression in the PFC are consistent with our previous report demonstrated significant genome-wide changes in global DNA methyation that we predicted would result in the dysregulation of hundreds of genes. Thus, epigenetic mechanisms that embed the transient peripheral injury into a long-term programmatic change in gene function in the brain may be contribution to these mechanisms [<xref ref-type="bibr" rid="B7">7</xref>].</p><p>Although we demonstrate a causal relationship between peripheral injury and a transcriptome change six months later, it is unknown whether these are the same changes that occurred in the brain at the time of injury or whether (and more probably) a cascade of gene expression alterations led to the chronic profile observed in our study. Furthermore, it is unknown if similar changes occur in other spinal or supraspinal regions. Further experiments are required at multiple time point and in additional brain regions, including those not implicated in pain signaling, before the significance of these findings can be fully understood. Finally, there is currently no evidence that these patterns are the cause of chronic pain or its associated co-morbidities. Nevertheless, our study strongly supports the plausibility that long-term changes in gene expression in the CNS are involved in chronic pain and its associated behaviors, and generates hypotheses on the genes and functional gene networks that might be involved.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Animals</title><p>8&#x02013;10 week-old male CD1 mice (Charles River, St-Constant, QC, Canada) were used. Animals were housed in ventilated polycarbonate cages and received water and standard laboratory rodent diet (Harlan Teklad, soy-free diet 2020X) <italic>ad libitum</italic>. All experiments were approved by the Animal Care Committee at McGill University, and conformed to the ethical guidelines of the Canadian Council on Animal Care and the guidelines of the Committee for Research and Ethical Issues of the International Association for the Study of Pain published in PAIN, 16 (1983) 109&#x02013;110. All surgery was performed under isoflurane anesthesia, and all efforts were made to minimize suffering.</p></sec><sec><title>Induction of nerve injury</title><p>Neuropathy was induced using the spared nerve injury model. Under deep anesthesia, an incision was made on the lateral surface of the thigh through the muscle, exposing the three terminal branches of the sciatic nerve: the sural, common peroneal and tibial nerves. The common peroneal and the tibial nerves were tightly ligated with 6.0 silk (Ethicon) and sectioned distal to the ligation. The sural nerve was left intact. Sham surgery involved exposing the nerve without damaging it [<xref ref-type="bibr" rid="B71">71</xref>,<xref ref-type="bibr" rid="B72">72</xref>].</p></sec><sec><title>Behavioral assessment</title><sec><title>Mechanical sensitivity</title><p>Calibrated monofilaments (Stoelting Co., Wood Dale, IL) were applied to the plantar surface of the hindpaw and the 50% threshold to withdraw (grams) was calculated as previously described [<xref ref-type="bibr" rid="B73">73</xref>]. The stimulus intensity ranged from 0.008 g to 4 g.</p></sec><sec><title>Cold sensitivity</title><p>A modified version of the acetone drop test [<xref ref-type="bibr" rid="B74">74</xref>] was used: total duration of acetone evoked behaviors (flinching, licking or biting) was measured for 1 minute after acetone (~25 &#x003bc;l) was applied to the plantar surface of the hindpaw.</p></sec><sec><title>Motor function</title><p>The accelerating rotarod assay was used (IITC Life Science Inc., Woodland Hills, CA) with the mouse adapter [<xref ref-type="bibr" rid="B75">75</xref>]. The task includes a speed ramp from 0 to 30 rpm over 60 s, followed by an additional 240 s at the maximal speed.</p></sec></sec><sec><title>Tissue extraction</title><p>Animals were sacrificed 6 months after nerve injury or sham surgery by decapitation following isoflurane anesthesia. Anatomical regions were defined according to the stereotaxic coordinates (rostral&#x02013;caudal, medial&#x02013;lateral and dorsal&#x02013;ventral from bregma) by Paxinos and Franklin [<xref ref-type="bibr" rid="B76">76</xref>]. The prefrontal cortex (right and left; +1 to +3, -1 to +1, 0 to &#x02212;2.5) was extracted, frozen on dry ice and stored at &#x02212;80 C until use.</p></sec><sec><title>RNA extraction and RNA sequencing</title><p>RNA was extracted with Trizol (Invitrogen) according to the manufacturer&#x02019;s protocol and treated with DNAse. cDNA libraries and RNA sequencing was performed by Genome Quebec on the Illumina Genome Analyzer IIX following Illumina guidelines.</p><sec><title>Expression validation</title><p>3 ug of RNA was used for cDNA conversion using random hexamers (Roche Molecular Biochemicals) according to manufacturer&#x02019;s guidelines. Expression primers were designed over overlapping exons with Autoprime.de [<xref ref-type="bibr" rid="B77">77</xref>] or specific to single exons that were differentially expressed in RNAseq and are shown in Additional file <xref ref-type="supplementary-material" rid="S3">3</xref>: Table S3. All reactions for all subjects (n=6-8 per group) were performed on the LightCycler 480 (Roche) in triplicate and statistical significance was determined as P&#x0003c;0.05 using one-tailed t-tests. Quantitative PCR was amplified with a pre-incubation at 95&#x000b0;C for 10 minutes followed by 45 cycles of [95&#x000b0;C for 10 seconds, 60&#x000b0;C for 10 seconds, 72&#x000b0;C for 10 sec] followed by 10 minutes of 72&#x000b0;C. Expression was measured relative to GAPDH expression, which demonstrated stable unchanged expression from RNAseq results.</p></sec></sec><sec><title>RNAseq analysis</title><p>Two animals were sequenced per condition with 36 bp reads with single end sequencing. RNAseq reads were aligned to the genome (mm9) using Top Hat [<xref ref-type="bibr" rid="B59">59</xref>,<xref ref-type="bibr" rid="B78">78</xref>]. Between 36 and 40 million reads aligned to unique genomic locations. Differential expression was determined from read counts per transcript, exon and 1000 bp genomic partition using Bioconductor [<xref ref-type="bibr" rid="B79">79</xref>] package DESeq [<xref ref-type="bibr" rid="B80">80</xref>] with default parameter settings. Transcript annotations were obtained from Ensembl version 63.37 (<ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org/">http://www.ensembl.org/</ext-link>). Concordance of read counts per 1000bp genomic partition between pairs of samples ranged between 0.88 to 0.99.</p><sec><title>Pathway analysis</title><p>Ingenuity Software was used to perform whole pathway analysis in the identification of affected networks and their relationship to each other based on the differential expression between SNI and Sham treated mice. Briefly, our data set containing gene identifiers and corresponding expression values was uploaded into the application. Each identifier was mapped to its corresponding object in the Ingenuity&#x000ae; Knowledge Base. Differentially expressed genes, called Network Eligible molecules, were overlaid onto a global molecular network developed from information contained in the Ingenuity Knowledge Base. Networks of Network Eligible Molecules were then algorithmically generated based on their connectivity. Pathways presented were chosen from following candidate gene validation (as indicated with asterisks in Table&#x02009;<xref ref-type="table" rid="T2">2</xref>). Right-tailed Fisher&#x02019;s exact test was used to calculate a p-value determining the probability that each pathway, biological function and/or disease assigned to that data set is due to chance alone.</p></sec></sec></sec><sec><title>Abbreviations</title><p>CLCA1: Calcium-activated chloride channel regulator 1; CNS: Central nervous system; GFAP: Glial fibrillary acidic protein; GRIN 1: Glutamate receptor, ionotropic, N-methyl D-aspartate 1; IPA: Ingenuity pathway analysis; KRT20: Keratin 20; LBP: Lipopolysaccharide binding protein; PCR: Polymerase chain reaction; PFC: prefrontal cortex; RNAseq: RNA sequencing; ROBO3: Roundabout, axon guidance receptor, homolog 3; SCN1A: Sodium channel, voltage -gated, type I, alpha subunit; SNI: Spared nerve injury; SYT2: Synaptotagmin II; XLR4B: X-linked lymphocyte-regulated 4B.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors&#x02019; contributions</title><p>SA and MT Overall experimental design, collecting the mouse behavioral data, performing RNA data collection and analysis and drafting the manuscript. MM Induction of nerve injury, collection of brain tissue Suderman: Bioinformatic analysis of RNAseq data. LSS Overall design of the experiments, supervision of the experiments and writing of the manuscript. Szyf: Overall design of the experiments, supervision of the experiments and writing of the manuscript. All authors have read and approved the final manuscript.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional file 1: Table S1</title><p>List of differentially regulated genes as revealed by RNAseq.</p></caption><media xlink:href="1744-8069-9-21-S1.xlsx"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S2"><caption><title>Additional file 2: Table S2</title><p>Ingenuity Pathway Analysis of altered biological functions in Sham vs. SNI PFC.</p></caption><media xlink:href="1744-8069-9-21-S2.xlsx"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S3"><caption><title>Additional file 3: Table S3</title><p>QPCR primer sets used for validation.</p></caption><media xlink:href="1744-8069-9-21-S3.xlsx"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><sec><title>Acknowledgements</title><p>This work was funded by CIHR MOP-102586 and, a FRSQ bourse de chercheur-boursier to LSS, a grant to MS from the CIHR MOP-42411 a gift from the Sackler McGill Program in Psychobiology and Epigenetics (MS) and a grant from the Canadian Institute for Advanced Research (MS). MT was supported by a studentship from The Louise and Alan Edwards Foundation.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Kuner</surname><given-names>R</given-names></name><article-title>Central mechanisms of pathological pain</article-title><source>Nat Med</source><year>2010</year><volume>16</volume><fpage>1258</fpage><lpage>1266</lpage><pub-id pub-id-type="doi">10.1038/nm.2231</pub-id><?supplied-pmid 20948531?><pub-id pub-id-type="pmid">20948531</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Xiao</surname><given-names>HS</given-names></name><name><surname>Huang</surname><given-names>QH</given-names></name><name><surname>Zhang</surname><given-names>FX</given-names></name><name><surname>Bao</surname><given-names>L</given-names></name><name><surname>Lu</surname><given-names>YJ</given-names></name><name><surname>Guo</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>WJ</given-names></name><name><surname>Fu</surname><given-names>G</given-names></name><name><surname>Xu</surname><given-names>SH</given-names></name><article-title>Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain</article-title><source>Proc Natl Acad Sci USA</source><year>2002</year><volume>99</volume><fpage>8360</fpage><lpage>8365</lpage><pub-id pub-id-type="doi">10.1073/pnas.122231899</pub-id><?supplied-pmid 12060780?><pub-id pub-id-type="pmid">12060780</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Grace</surname><given-names>PM</given-names></name><name><surname>Hurley</surname><given-names>D</given-names></name><name><surname>Barratt</surname><given-names>DT</given-names></name><name><surname>Tsykin</surname><given-names>A</given-names></name><name><surname>Watkins</surname><given-names>LR</given-names></name><name><surname>Rolan</surname><given-names>PE</given-names></name><name><surname>Hutchinson</surname><given-names>MR</given-names></name><article-title>Harnessing pain heterogeneity and RNA transcriptome to identify blood-based pain biomarkers: a novel correlational study design and bioinformatics approach in a graded chronic constriction injury model</article-title><source>J Neurochem</source><year>2012</year><volume>122</volume><fpage>976</fpage><lpage>994</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2012.07833.x</pub-id><?supplied-pmid 22697386?><pub-id pub-id-type="pmid">22697386</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Poh</surname><given-names>KW</given-names></name><name><surname>Yeo</surname><given-names>JF</given-names></name><name><surname>Stohler</surname><given-names>CS</given-names></name><name><surname>Ong</surname><given-names>WY</given-names></name><article-title>Comprehensive gene expression profiling in the prefrontal cortex links immune activation and neutrophil infiltration to antinociception</article-title><source>J Neurosci</source><year>2012</year><volume>32</volume><fpage>35</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2389-11.2012</pub-id><?supplied-pmid 22219268?><pub-id pub-id-type="pmid">22219268</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Tracey</surname><given-names>I</given-names></name><name><surname>Bushnell</surname><given-names>MC</given-names></name><article-title>How neuroimaging studies have challenged us to rethink: is chronic pain a disease?</article-title><source>J Pain</source><year>2009</year><volume>10</volume><fpage>1113</fpage><lpage>1120</lpage><pub-id pub-id-type="doi">10.1016/j.jpain.2009.09.001</pub-id><?supplied-pmid 19878862?><pub-id pub-id-type="pmid">19878862</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Schweinhardt</surname><given-names>P</given-names></name><name><surname>Bushnell</surname><given-names>MC</given-names></name><article-title>Pain imaging in health and disease&#x02013;how far have we come?</article-title><source>J Clin Invest</source><year>2010</year><volume>120</volume><fpage>3788</fpage><lpage>3797</lpage><pub-id pub-id-type="doi">10.1172/JCI43498</pub-id><?supplied-pmid 21041961?><pub-id pub-id-type="pmid">21041961</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Tajerian</surname><given-names>M</given-names></name><name><surname>Alvarado</surname><given-names>S</given-names></name><name><surname>Millecamps</surname><given-names>M</given-names></name><name><surname>Vachon</surname><given-names>P</given-names></name><name><surname>Crosby</surname><given-names>C</given-names></name><name><surname>Bushnell</surname><given-names>MC</given-names></name><name><surname>Szyf</surname><given-names>M</given-names></name><name><surname>Stone</surname><given-names>LS</given-names></name><article-title>Peripheral nerve injury is associated with chronic, reversible changes in global DNA methylation in the mouse prefrontal cortex</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e55259</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0055259</pub-id><?supplied-pmid 23383129?><pub-id pub-id-type="pmid">23383129</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Seminowicz</surname><given-names>DA</given-names></name><name><surname>Wideman</surname><given-names>TH</given-names></name><name><surname>Naso</surname><given-names>L</given-names></name><name><surname>Hatami-Khoroushahi</surname><given-names>Z</given-names></name><name><surname>Fallatah</surname><given-names>S</given-names></name><name><surname>Ware</surname><given-names>MA</given-names></name><name><surname>Jarzem</surname><given-names>P</given-names></name><name><surname>Bushnell</surname><given-names>MC</given-names></name><name><surname>Shir</surname><given-names>Y</given-names></name><name><surname>Ouellet</surname><given-names>JA</given-names></name><name><surname>Stone</surname><given-names>LS</given-names></name><article-title>Effective treatment of chronic low back pain in humans reverses abnormal brain anatomy and function</article-title><source>J Neurosci</source><year>2011</year><volume>31</volume><fpage>7540</fpage><lpage>7550</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5280-10.2011</pub-id><?supplied-pmid 21593339?><pub-id pub-id-type="pmid">21593339</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Metz</surname><given-names>AE</given-names></name><name><surname>Yau</surname><given-names>HJ</given-names></name><name><surname>Centeno</surname><given-names>MV</given-names></name><name><surname>Apkarian</surname><given-names>AV</given-names></name><name><surname>Martina</surname><given-names>M</given-names></name><article-title>Morphological and functional reorganization of rat medial prefrontal cortex in neuropathic pain</article-title><source>Proc Natl Acad Sci USA</source><year>2009</year><volume>106</volume><fpage>2423</fpage><lpage>2428</lpage><pub-id pub-id-type="doi">10.1073/pnas.0809897106</pub-id><?supplied-pmid 19171885?><pub-id pub-id-type="pmid">19171885</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Seminowicz</surname><given-names>DA</given-names></name><name><surname>Laferriere</surname><given-names>AL</given-names></name><name><surname>Millecamps</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>JS</given-names></name><name><surname>Coderre</surname><given-names>TJ</given-names></name><name><surname>Bushnell</surname><given-names>MC</given-names></name><article-title>MRI structural brain changes associated with sensory and emotional function in a rat model of long-term neuropathic pain</article-title><source>NeuroImage</source><year>2009</year><volume>47</volume><fpage>1007</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2009.05.068</pub-id><?supplied-pmid 19497372?><pub-id pub-id-type="pmid">19497372</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Augustinsson</surname><given-names>LE</given-names></name><name><surname>Sullivan</surname><given-names>L</given-names></name><name><surname>Sullivan</surname><given-names>M</given-names></name><article-title>Physical, psychologic, and social function in chronic pain patients after epidural spinal electrical stimulation</article-title><source>Spine (Phila Pa 1976)</source><year>1986</year><volume>11</volume><fpage>111</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1097/00007632-198603000-00002</pub-id><pub-id pub-id-type="pmid">2422768</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Metzker</surname><given-names>ML</given-names></name><article-title>Sequencing technologies - the next generation</article-title><source>Nat Rev Genet</source><year>2010</year><volume>11</volume><fpage>31</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1038/nrg2626</pub-id><?supplied-pmid 19997069?><pub-id pub-id-type="pmid">19997069</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Batten</surname><given-names>ML</given-names></name><name><surname>Imanishi</surname><given-names>Y</given-names></name><name><surname>Maeda</surname><given-names>T</given-names></name><name><surname>Tu</surname><given-names>DC</given-names></name><name><surname>Moise</surname><given-names>AR</given-names></name><name><surname>Bronson</surname><given-names>D</given-names></name><name><surname>Possin</surname><given-names>D</given-names></name><name><surname>Van Gelder</surname><given-names>RN</given-names></name><name><surname>Baehr</surname><given-names>W</given-names></name><name><surname>Palczewski</surname><given-names>K</given-names></name><article-title>Lecithin-retinol acyltransferase is essential for accumulation of all-trans-retinyl esters in the eye and in the liver</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>10422</fpage><lpage>10432</lpage><?supplied-pmid 14684738?><pub-id pub-id-type="pmid">14684738</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Shiao</surname><given-names>T</given-names></name><name><surname>Tran</surname><given-names>P</given-names></name><name><surname>Siegel</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Vasiliou</surname><given-names>V</given-names></name><article-title>Four amino acid changes are associated with the Aldh3a1 locus polymorphism in mice which may be responsible for corneal sensitivity to ultraviolet light</article-title><source>Pharmacogenetics</source><year>1999</year><volume>9</volume><fpage>145</fpage><lpage>153</lpage><?supplied-pmid 10376761?><pub-id pub-id-type="pmid">10376761</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Bulgakova</surname><given-names>NA</given-names></name><name><surname>Knust</surname><given-names>E</given-names></name><article-title>The Crumbs complex: from epithelial-cell polarity to retinal degeneration</article-title><source>J Cell Sci</source><year>2009</year><volume>122</volume><fpage>2587</fpage><lpage>2596</lpage><pub-id pub-id-type="doi">10.1242/jcs.023648</pub-id><?supplied-pmid 19625503?><pub-id pub-id-type="pmid">19625503</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Mercer</surname><given-names>TR</given-names></name><name><surname>Gerhardt</surname><given-names>DJ</given-names></name><name><surname>Dinger</surname><given-names>ME</given-names></name><name><surname>Crawford</surname><given-names>J</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Jeddeloh</surname><given-names>JA</given-names></name><name><surname>Mattick</surname><given-names>JS</given-names></name><name><surname>Rinn</surname><given-names>JL</given-names></name><article-title>Targeted RNA sequencing reveals the deep complexity of the human transcriptome</article-title><source>Nat Biotechnol</source><year>2012</year><volume>30</volume><fpage>99</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">22081020</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="other"><name><surname>Wood</surname><given-names>SH</given-names></name><name><surname>Craig</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Merry</surname><given-names>B</given-names></name><name><surname>de Magalhaes</surname><given-names>JP</given-names></name><article-title>Whole transcriptome sequencing of the aging rat brain reveals dynamic RNA changes in the dark matter of the genome</article-title><source>Age (Dordr)</source><year>2012</year></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Wilson</surname><given-names>BA</given-names></name><name><surname>Masel</surname><given-names>J</given-names></name><article-title>Putatively noncoding transcripts show extensive association with ribosomes</article-title><source>Genome Biol Evol</source><year>2011</year><volume>3</volume><fpage>1245</fpage><lpage>1252</lpage><pub-id pub-id-type="doi">10.1093/gbe/evr099</pub-id><?supplied-pmid 21948395?><pub-id pub-id-type="pmid">21948395</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Kishore</surname><given-names>S</given-names></name><name><surname>Stamm</surname><given-names>S</given-names></name><article-title>The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C</article-title><source>Science</source><year>2006</year><volume>311</volume><fpage>230</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1126/science.1118265</pub-id><?supplied-pmid 16357227?><pub-id pub-id-type="pmid">16357227</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Yao</surname><given-names>MJ</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Zhao</surname><given-names>PP</given-names></name><name><surname>Lu</surname><given-names>MH</given-names></name><name><surname>Jian</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>MF</given-names></name><name><surname>Yuan</surname><given-names>XB</given-names></name><article-title>Transcriptome analysis of microRNAs in developing cerebral cortex of rat</article-title><source>BMC Genomics</source><year>2012</year><volume>13</volume><fpage>232</fpage><pub-id pub-id-type="doi">10.1186/1471-2164-13-232</pub-id><?supplied-pmid 22691069?><pub-id pub-id-type="pmid">22691069</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Nicholson</surname><given-names>B</given-names></name><name><surname>Verma</surname><given-names>S</given-names></name><article-title>Comorbidities in chronic neuropathic pain</article-title><source>Pain Med</source><year>2004</year><volume>5</volume><issue>Suppl 1</issue><fpage>S9</fpage><lpage>S27</lpage><?supplied-pmid 14996227?><pub-id pub-id-type="pmid">14996227</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Choi</surname><given-names>JM</given-names></name><name><surname>Padmala</surname><given-names>S</given-names></name><name><surname>Pessoa</surname><given-names>L</given-names></name><article-title>Impact of state anxiety on the interaction between threat monitoring and cognition</article-title><source>NeuroImage</source><year>2012</year><volume>59</volume><fpage>1912</fpage><lpage>1923</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.08.102</pub-id><?supplied-pmid 21939773?><pub-id pub-id-type="pmid">21939773</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Drevets</surname><given-names>WC</given-names></name><article-title>Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression</article-title><source>Prog Brain Res</source><year>2000</year><volume>126</volume><fpage>413</fpage><lpage>431</lpage><?supplied-pmid 11105660?><pub-id pub-id-type="pmid">11105660</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Drummond</surname><given-names>SP</given-names></name><name><surname>Brown</surname><given-names>GG</given-names></name><name><surname>Gillin</surname><given-names>JC</given-names></name><name><surname>Stricker</surname><given-names>JL</given-names></name><name><surname>Wong</surname><given-names>EC</given-names></name><name><surname>Buxton</surname><given-names>RB</given-names></name><article-title>Altered brain response to verbal learning following sleep deprivation</article-title><source>Nature</source><year>2000</year><volume>403</volume><fpage>655</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1038/35001068</pub-id><?supplied-pmid 10688201?><pub-id pub-id-type="pmid">10688201</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Zlatic</surname><given-names>M</given-names></name><name><surname>Landgraf</surname><given-names>M</given-names></name><name><surname>Bate</surname><given-names>M</given-names></name><article-title>Genetic specification of axonal arbors: atonal regulates robo3 to position terminal branches in the Drosophila nervous system</article-title><source>Neuron</source><year>2003</year><volume>37</volume><fpage>41</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(02)01131-5</pub-id><?supplied-pmid 12526771?><pub-id pub-id-type="pmid">12526771</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Barber</surname><given-names>M</given-names></name><name><surname>Di Meglio</surname><given-names>T</given-names></name><name><surname>Andrews</surname><given-names>WD</given-names></name><name><surname>Hernandez-Miranda</surname><given-names>LR</given-names></name><name><surname>Murakami</surname><given-names>F</given-names></name><name><surname>Chedotal</surname><given-names>A</given-names></name><name><surname>Parnavelas</surname><given-names>JG</given-names></name><article-title>The role of Robo3 in the development of cortical interneurons</article-title><source>Cereb Cortex</source><year>2009</year><volume>19</volume><issue>Suppl 1</issue><fpage>i22</fpage><lpage>31</lpage><?supplied-pmid 19366869?><pub-id pub-id-type="pmid">19366869</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Couch</surname><given-names>JA</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Rieff</surname><given-names>HI</given-names></name><name><surname>Uri</surname><given-names>EM</given-names></name><name><surname>Condron</surname><given-names>BG</given-names></name><article-title>robo2 and robo3 interact with eagle to regulate serotonergic neuron differentiation</article-title><source>Development</source><year>2004</year><volume>131</volume><fpage>997</fpage><lpage>1006</lpage><pub-id pub-id-type="doi">10.1242/dev.00962</pub-id><?supplied-pmid 14973268?><pub-id pub-id-type="pmid">14973268</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Raefski</surname><given-names>AS</given-names></name><name><surname>O'Neill</surname><given-names>MJ</given-names></name><article-title>Identification of a cluster of X-linked imprinted genes in mice</article-title><source>Nat Genet</source><year>2005</year><volume>37</volume><fpage>620</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1038/ng1567</pub-id><?supplied-pmid 15908953?><pub-id pub-id-type="pmid">15908953</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Cubelos</surname><given-names>B</given-names></name><name><surname>Sebastian-Serrano</surname><given-names>A</given-names></name><name><surname>Beccari</surname><given-names>L</given-names></name><name><surname>Calcagnotto</surname><given-names>ME</given-names></name><name><surname>Cisneros</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Dopazo</surname><given-names>A</given-names></name><name><surname>Alvarez-Dolado</surname><given-names>M</given-names></name><name><surname>Redondo</surname><given-names>JM</given-names></name><name><surname>Bovolenta</surname><given-names>P</given-names></name><article-title>Cux1 and Cux2 regulate dendritic branching, spine morphology, and synapses of the upper layer neurons of the cortex</article-title><source>Neuron</source><year>2010</year><volume>66</volume><fpage>523</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2010.04.038</pub-id><?supplied-pmid 20510857?><pub-id pub-id-type="pmid">20510857</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Gruber</surname><given-names>AD</given-names></name><name><surname>Elble</surname><given-names>RC</given-names></name><name><surname>Ji</surname><given-names>HL</given-names></name><name><surname>Schreur</surname><given-names>KD</given-names></name><name><surname>Fuller</surname><given-names>CM</given-names></name><name><surname>Pauli</surname><given-names>BU</given-names></name><article-title>Genomic cloning, molecular characterization, and functional analysis of human CLCA1, the first human member of the family of Ca2+&#x02212;activated Cl- channel proteins</article-title><source>Genomics</source><year>1998</year><volume>54</volume><fpage>200</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1006/geno.1998.5562</pub-id><?supplied-pmid 9828122?><pub-id pub-id-type="pmid">9828122</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Hartzell</surname><given-names>C</given-names></name><name><surname>Putzier</surname><given-names>I</given-names></name><name><surname>Arreola</surname><given-names>J</given-names></name><article-title>Calcium-activated chloride channels</article-title><source>Annu Rev Physiol</source><year>2005</year><volume>67</volume><fpage>719</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1146/annurev.physiol.67.032003.154341</pub-id><?supplied-pmid 15709976?><pub-id pub-id-type="pmid">15709976</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Wahl</surname><given-names>AS</given-names></name><name><surname>Buchthal</surname><given-names>B</given-names></name><name><surname>Rode</surname><given-names>F</given-names></name><name><surname>Bomholt</surname><given-names>SF</given-names></name><name><surname>Freitag</surname><given-names>HE</given-names></name><name><surname>Hardingham</surname><given-names>GE</given-names></name><name><surname>Ronn</surname><given-names>LC</given-names></name><name><surname>Bading</surname><given-names>H</given-names></name><article-title>Hypoxic/ischemic conditions induce expression of the putative pro-death gene Clca1 via activation of extrasynaptic N-methyl-D-aspartate receptors</article-title><source>Neuroscience</source><year>2009</year><volume>158</volume><fpage>344</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.06.018</pub-id><?supplied-pmid 18616988?><pub-id pub-id-type="pmid">18616988</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Moayedi</surname><given-names>M</given-names></name><name><surname>Weissman-Fogel</surname><given-names>I</given-names></name><name><surname>Salomons</surname><given-names>TV</given-names></name><name><surname>Crawley</surname><given-names>AP</given-names></name><name><surname>Goldberg</surname><given-names>MB</given-names></name><name><surname>Freeman</surname><given-names>BV</given-names></name><name><surname>Tenenbaum</surname><given-names>HC</given-names></name><name><surname>Davis</surname><given-names>KD</given-names></name><article-title>Abnormal gray matter aging in chronic pain patients</article-title><source>Brain Res</source><year>2012</year><volume>1456</volume><fpage>82</fpage><lpage>93</lpage><?supplied-pmid 22503149?><pub-id pub-id-type="pmid">22503149</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>As-Sanie</surname><given-names>S</given-names></name><name><surname>Harris</surname><given-names>RE</given-names></name><name><surname>Napadow</surname><given-names>V</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Neshewat</surname><given-names>G</given-names></name><name><surname>Kairys</surname><given-names>A</given-names></name><name><surname>Williams</surname><given-names>D</given-names></name><name><surname>Clauw</surname><given-names>DJ</given-names></name><name><surname>Schmidt-Wilcke</surname><given-names>T</given-names></name><article-title>Changes in regional gray matter volume in women with chronic pelvic pain: a voxel-based morphometry study</article-title><source>Pain</source><year>2012</year><volume>153</volume><fpage>1006</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2012.01.032</pub-id><?supplied-pmid 22387096?><pub-id pub-id-type="pmid">22387096</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Szabo</surname><given-names>N</given-names></name><name><surname>Kincses</surname><given-names>ZT</given-names></name><name><surname>Pardutz</surname><given-names>A</given-names></name><name><surname>Tajti</surname><given-names>J</given-names></name><name><surname>Szok</surname><given-names>D</given-names></name><name><surname>Tuka</surname><given-names>B</given-names></name><name><surname>Kiraly</surname><given-names>A</given-names></name><name><surname>Babos</surname><given-names>M</given-names></name><name><surname>Voros</surname><given-names>E</given-names></name><name><surname>Bomboi</surname><given-names>G</given-names></name><article-title>White matter microstructural alterations in migraine: a diffusion-weighted MRI study</article-title><source>Pain</source><year>2012</year><volume>153</volume><fpage>651</fpage><lpage>656</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2011.11.029</pub-id><?supplied-pmid 22244439?><pub-id pub-id-type="pmid">22244439</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Dai</surname><given-names>S</given-names></name><name><surname>An</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Xiong</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>M</given-names></name><article-title>Chronic but not acute treatment with caffeine attenuates traumatic brain injury in the mouse cortical impact model</article-title><source>Neuroscience</source><year>2008</year><volume>151</volume><fpage>1198</fpage><lpage>1207</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2007.11.020</pub-id><?supplied-pmid 18207647?><pub-id pub-id-type="pmid">18207647</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Nabekura</surname><given-names>J</given-names></name><article-title>Rapid synaptic remodeling in the adult somatosensory cortex following peripheral nerve injury and its association with neuropathic pain</article-title><source>J Neurosci</source><year>2011</year><volume>31</volume><fpage>5477</fpage><lpage>5482</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0328-11.2011</pub-id><?supplied-pmid 21471384?><pub-id pub-id-type="pmid">21471384</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Eto</surname><given-names>K</given-names></name><name><surname>Nabekura</surname><given-names>J</given-names></name><article-title>Synaptic structure and function in the mouse somatosensory cortex during chronic pain: in vivo two-photon imaging</article-title><source>Neural Plast</source><year>2012</year><volume>2012</volume><fpage>640259</fpage><?supplied-pmid 22530157?><pub-id pub-id-type="pmid">22530157</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><name><surname>Eto</surname><given-names>K</given-names></name><name><surname>Wake</surname><given-names>H</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Ishibashi</surname><given-names>H</given-names></name><name><surname>Noda</surname><given-names>M</given-names></name><name><surname>Yanagawa</surname><given-names>Y</given-names></name><name><surname>Nabekura</surname><given-names>J</given-names></name><article-title>Inter-regional contribution of enhanced activity of the primary somatosensory cortex to the anterior cingulate cortex accelerates chronic pain behavior</article-title><source>J Neurosci</source><year>2011</year><volume>31</volume><fpage>7631</fpage><lpage>7636</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0946-11.2011</pub-id><?supplied-pmid 21613476?><pub-id pub-id-type="pmid">21613476</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><name><surname>Apkarian</surname><given-names>AV</given-names></name><name><surname>Sosa</surname><given-names>Y</given-names></name><name><surname>Krauss</surname><given-names>BR</given-names></name><name><surname>Thomas</surname><given-names>PS</given-names></name><name><surname>Fredrickson</surname><given-names>BE</given-names></name><name><surname>Levy</surname><given-names>RE</given-names></name><name><surname>Harden</surname><given-names>RN</given-names></name><name><surname>Chialvo</surname><given-names>DR</given-names></name><article-title>Chronic pain patients are impaired on an emotional decision-making task</article-title><source>Pain</source><year>2004</year><volume>108</volume><fpage>129</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2003.12.015</pub-id><?supplied-pmid 15109516?><pub-id pub-id-type="pmid">15109516</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><name><surname>Gore</surname><given-names>M</given-names></name><name><surname>Sadosky</surname><given-names>A</given-names></name><name><surname>Stacey</surname><given-names>BR</given-names></name><name><surname>Tai</surname><given-names>KS</given-names></name><name><surname>Leslie</surname><given-names>D</given-names></name><article-title>The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings</article-title><source>Spine (Phila Pa 1976)</source><year>2012</year><volume>37</volume><fpage>E668</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1097/BRS.0b013e318241e5de</pub-id><pub-id pub-id-type="pmid">22146287</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Wood</surname><given-names>JN</given-names></name><article-title>The roles of sodium channels in nociception: implications for mechanisms of neuropathic pain</article-title><source>Pain Med</source><year>2011</year><volume>12</volume><issue>Suppl 3</issue><fpage>S93</fpage><lpage>99</lpage><?supplied-pmid 21752183?><pub-id pub-id-type="pmid">21752183</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><name><surname>Dib-Hajj</surname><given-names>SD</given-names></name><name><surname>Cummins</surname><given-names>TR</given-names></name><name><surname>Black</surname><given-names>JA</given-names></name><name><surname>Waxman</surname><given-names>SG</given-names></name><article-title>Sodium channels in normal and pathological pain</article-title><source>Annu Rev Neurosci</source><year>2010</year><volume>33</volume><fpage>325</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1146/annurev-neuro-060909-153234</pub-id><?supplied-pmid 20367448?><pub-id pub-id-type="pmid">20367448</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><name><surname>Escayg</surname><given-names>A</given-names></name><name><surname>MacDonald</surname><given-names>BT</given-names></name><name><surname>Meisler</surname><given-names>MH</given-names></name><name><surname>Baulac</surname><given-names>S</given-names></name><name><surname>Huberfeld</surname><given-names>G</given-names></name><name><surname>An-Gourfinkel</surname><given-names>I</given-names></name><name><surname>Brice</surname><given-names>A</given-names></name><name><surname>LeGuern</surname><given-names>E</given-names></name><name><surname>Moulard</surname><given-names>B</given-names></name><name><surname>Chaigne</surname><given-names>D</given-names></name><article-title>Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2</article-title><source>Nat Genet</source><year>2000</year><volume>24</volume><fpage>343</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1038/74159</pub-id><?supplied-pmid 10742094?><pub-id pub-id-type="pmid">10742094</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><name><surname>Dichgans</surname><given-names>M</given-names></name><name><surname>Freilinger</surname><given-names>T</given-names></name><name><surname>Eckstein</surname><given-names>G</given-names></name><name><surname>Babini</surname><given-names>E</given-names></name><name><surname>Lorenz-Depiereux</surname><given-names>B</given-names></name><name><surname>Biskup</surname><given-names>S</given-names></name><name><surname>Ferrari</surname><given-names>MD</given-names></name><name><surname>Herzog</surname><given-names>J</given-names></name><name><surname>van den Maagdenberg</surname><given-names>AM</given-names></name><name><surname>Pusch</surname><given-names>M</given-names></name><name><surname>Strom</surname><given-names>TM</given-names></name><article-title>Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine</article-title><source>Lancet</source><year>2005</year><volume>366</volume><fpage>371</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(05)66786-4</pub-id><?supplied-pmid 16054936?><pub-id pub-id-type="pmid">16054936</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><name><surname>Meier</surname><given-names>S</given-names></name><name><surname>Demirakca</surname><given-names>T</given-names></name><name><surname>Brusniak</surname><given-names>W</given-names></name><name><surname>Wolf</surname><given-names>I</given-names></name><name><surname>Liebsch</surname><given-names>K</given-names></name><name><surname>Tunc-Skarka</surname><given-names>N</given-names></name><name><surname>Nieratschker</surname><given-names>V</given-names></name><name><surname>Witt</surname><given-names>SH</given-names></name><name><surname>Matthaus</surname><given-names>F</given-names></name><name><surname>Ende</surname><given-names>G</given-names></name><article-title>SCN1A Affects Brain Structure and the Neural Activity of the Aging Brain</article-title><source>Biol Psychiatry</source><year>2012</year><volume>72</volume><fpage>677</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2012.03.017</pub-id><?supplied-pmid 22534457?><pub-id pub-id-type="pmid">22534457</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><name><surname>Eijkelkamp</surname><given-names>N</given-names></name><name><surname>Linley</surname><given-names>JE</given-names></name><name><surname>Baker</surname><given-names>MD</given-names></name><name><surname>Minett</surname><given-names>MS</given-names></name><name><surname>Cregg</surname><given-names>R</given-names></name><name><surname>Werdehausen</surname><given-names>R</given-names></name><name><surname>Rugiero</surname><given-names>F</given-names></name><name><surname>Wood</surname><given-names>JN</given-names></name><article-title>Neurological perspectives on voltage-gated sodium channels</article-title><source>Brain</source><year>2012</year><volume>135</volume><fpage>2585</fpage><lpage>2612</lpage><pub-id pub-id-type="doi">10.1093/brain/aws225</pub-id><?supplied-pmid 22961543?><pub-id pub-id-type="pmid">22961543</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><name><surname>Hains</surname><given-names>BC</given-names></name><name><surname>Saab</surname><given-names>CY</given-names></name><name><surname>Klein</surname><given-names>JP</given-names></name><name><surname>Craner</surname><given-names>MJ</given-names></name><name><surname>Waxman</surname><given-names>SG</given-names></name><article-title>Altered sodium channel expression in second-order spinal sensory neurons contributes to pain after peripheral nerve injury</article-title><source>J Neurosci</source><year>2004</year><volume>24</volume><fpage>4832</fpage><lpage>4839</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0300-04.2004</pub-id><?supplied-pmid 15152043?><pub-id pub-id-type="pmid">15152043</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><name><surname>Cheah</surname><given-names>CS</given-names></name><name><surname>Yu</surname><given-names>FH</given-names></name><name><surname>Westenbroek</surname><given-names>RE</given-names></name><name><surname>Kalume</surname><given-names>FK</given-names></name><name><surname>Oakley</surname><given-names>JC</given-names></name><name><surname>Potter</surname><given-names>GB</given-names></name><name><surname>Rubenstein</surname><given-names>JL</given-names></name><name><surname>Catterall</surname><given-names>WA</given-names></name><article-title>Specific deletion of NaV1.1 sodium channels in inhibitory interneurons causes seizures and premature death in a mouse model of Dravet syndrome</article-title><source>Proc Natl Acad Sci USA</source><year>2012</year><volume>109</volume><fpage>14646</fpage><lpage>14651</lpage><pub-id pub-id-type="doi">10.1073/pnas.1211591109</pub-id><?supplied-pmid 22908258?><pub-id pub-id-type="pmid">22908258</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><name><surname>Petrenko</surname><given-names>AG</given-names></name><name><surname>Perin</surname><given-names>MS</given-names></name><name><surname>Davletov</surname><given-names>BA</given-names></name><name><surname>Ushkaryov</surname><given-names>YA</given-names></name><name><surname>Geppert</surname><given-names>M</given-names></name><name><surname>Sudhof</surname><given-names>TC</given-names></name><article-title>Binding of synaptotagmin to the alpha-latrotoxin receptor implicates both in synaptic vesicle exocytosis</article-title><source>Nature</source><year>1991</year><volume>353</volume><fpage>65</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1038/353065a0</pub-id><?supplied-pmid 1881448?><pub-id pub-id-type="pmid">1881448</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><name><surname>Bragina</surname><given-names>L</given-names></name><name><surname>Fattorini</surname><given-names>G</given-names></name><name><surname>Giovedi</surname><given-names>S</given-names></name><name><surname>Melone</surname><given-names>M</given-names></name><name><surname>Bosco</surname><given-names>F</given-names></name><name><surname>Benfenati</surname><given-names>F</given-names></name><name><surname>Conti</surname><given-names>F</given-names></name><article-title>Analysis of Synaptotagmin, SV2, and Rab3 Expression in Cortical Glutamatergic and GABAergic Axon Terminals</article-title><source>Front Cell Neurosci</source><year>2011</year><volume>5</volume><fpage>32</fpage><?supplied-pmid 22275882?><pub-id pub-id-type="pmid">22275882</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><name><surname>Ji</surname><given-names>G</given-names></name><name><surname>Neugebauer</surname><given-names>V</given-names></name><article-title>Pain-related deactivation of medial prefrontal cortical neurons involves mGluR1 and GABA(A) receptors</article-title><source>J Neurophysiol</source><year>2011</year><volume>106</volume><fpage>2642</fpage><lpage>2652</lpage><pub-id pub-id-type="doi">10.1152/jn.00461.2011</pub-id><?supplied-pmid 21880942?><pub-id pub-id-type="pmid">21880942</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><name><surname>Muta</surname><given-names>T</given-names></name><name><surname>Takeshige</surname><given-names>K</given-names></name><article-title>Essential roles of CD14 and lipopolysaccharide-binding protein for activation of toll-like receptor (TLR)2 as well as TLR4 Reconstitution of TLR2- and TLR4-activation by distinguishable ligands in LPS preparations</article-title><source>Eur J Biochem</source><year>2001</year><volume>268</volume><fpage>4580</fpage><lpage>4589</lpage><pub-id pub-id-type="doi">10.1046/j.1432-1327.2001.02385.x</pub-id><?supplied-pmid 11502220?><pub-id pub-id-type="pmid">11502220</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Simen</surname><given-names>A</given-names></name><name><surname>Mane</surname><given-names>S</given-names></name><name><surname>Kaffman</surname><given-names>A</given-names></name><article-title>Early life stress inhibits expression of a novel innate immune pathway in the developing hippocampus</article-title><source>Neuropsychopharmacology</source><year>2012</year><volume>37</volume><fpage>567</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1038/npp.2011.239</pub-id><?supplied-pmid 21993208?><pub-id pub-id-type="pmid">21993208</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><name><surname>Garate</surname><given-names>I</given-names></name><name><surname>Garcia-Bueno</surname><given-names>B</given-names></name><name><surname>Madrigal</surname><given-names>JL</given-names></name><name><surname>Bravo</surname><given-names>L</given-names></name><name><surname>Berrocoso</surname><given-names>E</given-names></name><name><surname>Caso</surname><given-names>JR</given-names></name><name><surname>Mico</surname><given-names>JA</given-names></name><name><surname>Leza</surname><given-names>JC</given-names></name><article-title>Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression</article-title><source>J Neuroinflammation</source><year>2011</year><volume>8</volume><fpage>151</fpage><pub-id pub-id-type="doi">10.1186/1742-2094-8-151</pub-id><?supplied-pmid 22053929?><pub-id pub-id-type="pmid">22053929</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>PE</given-names></name><name><surname>Errington</surname><given-names>ML</given-names></name><name><surname>Kneussel</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Annala</surname><given-names>AJ</given-names></name><name><surname>Rudhard</surname><given-names>YH</given-names></name><name><surname>Rast</surname><given-names>GF</given-names></name><name><surname>Specht</surname><given-names>CG</given-names></name><name><surname>Tigaret</surname><given-names>CM</given-names></name><name><surname>Nassar</surname><given-names>MA</given-names></name><article-title>Behavioral deficits and subregion-specific suppression of LTP in mice expressing a population of mutant NMDA receptors throughout the hippocampus</article-title><source>Learn Mem</source><year>2009</year><volume>16</volume><fpage>635</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1101/lm.1316909</pub-id><?supplied-pmid 19794189?><pub-id pub-id-type="pmid">19794189</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><name><surname>Sakurai</surname><given-names>K</given-names></name><name><surname>Toru</surname><given-names>M</given-names></name><name><surname>Yamakawa-Kobayashi</surname><given-names>K</given-names></name><name><surname>Arinami</surname><given-names>T</given-names></name><article-title>Mutation analysis of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia</article-title><source>Neurosci Lett</source><year>2000</year><volume>296</volume><fpage>168</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1016/S0304-3940(00)01599-8</pub-id><?supplied-pmid 11109007?><pub-id pub-id-type="pmid">11109007</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><name><surname>Tarabeux</surname><given-names>J</given-names></name><name><surname>Kebir</surname><given-names>O</given-names></name><name><surname>Gauthier</surname><given-names>J</given-names></name><name><surname>Hamdan</surname><given-names>FF</given-names></name><name><surname>Xiong</surname><given-names>L</given-names></name><name><surname>Piton</surname><given-names>A</given-names></name><name><surname>Spiegelman</surname><given-names>D</given-names></name><name><surname>Henrion</surname><given-names>E</given-names></name><name><surname>Millet</surname><given-names>B</given-names></name><name><surname>Fathalli</surname><given-names>F</given-names></name><article-title>Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia</article-title><source>Transl Psychiatry</source><year>2011</year><volume>1</volume><fpage>e55</fpage><pub-id pub-id-type="doi">10.1038/tp.2011.52</pub-id><?supplied-pmid 22833210?><pub-id pub-id-type="pmid">22833210</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><name><surname>Hamdan</surname><given-names>FF</given-names></name><name><surname>Gauthier</surname><given-names>J</given-names></name><name><surname>Araki</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>DT</given-names></name><name><surname>Yoshizawa</surname><given-names>Y</given-names></name><name><surname>Higashi</surname><given-names>K</given-names></name><name><surname>Park</surname><given-names>AR</given-names></name><name><surname>Spiegelman</surname><given-names>D</given-names></name><name><surname>Dobrzeniecka</surname><given-names>S</given-names></name><name><surname>Piton</surname><given-names>A</given-names></name><article-title>Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability</article-title><source>Am J Hum Genet</source><year>2011</year><volume>88</volume><fpage>306</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2011.02.001</pub-id><?supplied-pmid 21376300?><pub-id pub-id-type="pmid">21376300</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><name><surname>Labrie</surname><given-names>V</given-names></name><name><surname>Clapcote</surname><given-names>SJ</given-names></name><name><surname>Roder</surname><given-names>JC</given-names></name><article-title>Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors</article-title><source>Pharmacol Biochem Behav</source><year>2009</year><volume>91</volume><fpage>610</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1016/j.pbb.2008.09.016</pub-id><?supplied-pmid 18940194?><pub-id pub-id-type="pmid">18940194</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><name><surname>Furuse</surname><given-names>T</given-names></name><name><surname>Wada</surname><given-names>Y</given-names></name><name><surname>Hattori</surname><given-names>K</given-names></name><name><surname>Yamada</surname><given-names>I</given-names></name><name><surname>Kushida</surname><given-names>T</given-names></name><name><surname>Shibukawa</surname><given-names>Y</given-names></name><name><surname>Masuya</surname><given-names>H</given-names></name><name><surname>Kaneda</surname><given-names>H</given-names></name><name><surname>Miura</surname><given-names>I</given-names></name><name><surname>Seno</surname><given-names>N</given-names></name><article-title>Phenotypic characterization of a new Grin1 mutant mouse generated by ENU mutagenesis</article-title><source>Eur J Neurosci</source><year>2010</year><volume>31</volume><fpage>1281</fpage><lpage>1291</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2010.07164.x</pub-id><?supplied-pmid 20345915?><pub-id pub-id-type="pmid">20345915</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Pu</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Du</surname><given-names>D</given-names></name><article-title>Brain-derived neurotrophic factor-activated astrocytes produce mechanical allodynia in neuropathic pain</article-title><source>Neuroscience</source><year>2011</year><volume>199</volume><fpage>452</fpage><lpage>460</lpage><?supplied-pmid 22044922?><pub-id pub-id-type="pmid">22044922</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><name><surname>Piao</surname><given-names>ZG</given-names></name><name><surname>Cho</surname><given-names>IH</given-names></name><name><surname>Park</surname><given-names>CK</given-names></name><name><surname>Hong</surname><given-names>JP</given-names></name><name><surname>Choi</surname><given-names>SY</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Oh</surname><given-names>SB</given-names></name><article-title>Activation of glia and microglial p38 MAPK in medullary dorsal horn contributes to tactile hypersensitivity following trigeminal sensory nerve injury</article-title><source>Pain</source><year>2006</year><volume>121</volume><fpage>219</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2005.12.023</pub-id><?supplied-pmid 16495005?><pub-id pub-id-type="pmid">16495005</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>FL</given-names></name><name><surname>Dong</surname><given-names>YL</given-names></name><name><surname>Zhang</surname><given-names>ZJ</given-names></name><name><surname>Cao</surname><given-names>DL</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Hui</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>YJ</given-names></name><article-title>Activation of astrocytes in the anterior cingulate cortex contributes to the affective component of pain in an inflammatory pain model</article-title><source>Brain Res Bull</source><year>2012</year><volume>87</volume><fpage>60</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.brainresbull.2011.09.022</pub-id><?supplied-pmid 22004615?><pub-id pub-id-type="pmid">22004615</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>YJ</given-names></name><article-title>Pain-related aversion induces astrocytic reaction and proinflammatory cytokine expression in the anterior cingulate cortex in rats</article-title><source>Brain Res Bull</source><year>2011</year><volume>84</volume><fpage>178</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1016/j.brainresbull.2010.12.007</pub-id><?supplied-pmid 21168476?><pub-id pub-id-type="pmid">21168476</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><name><surname>Kuzumaki</surname><given-names>N</given-names></name><name><surname>Narita</surname><given-names>M</given-names></name><name><surname>Hareyama</surname><given-names>N</given-names></name><name><surname>Niikura</surname><given-names>K</given-names></name><name><surname>Nagumo</surname><given-names>Y</given-names></name><name><surname>Nozaki</surname><given-names>H</given-names></name><name><surname>Amano</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><article-title>Chronic pain-induced astrocyte activation in the cingulate cortex with no change in neural or glial differentiation from neural stem cells in mice</article-title><source>Neurosci Lett</source><year>2007</year><volume>415</volume><fpage>22</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2006.12.057</pub-id><?supplied-pmid 17316991?><pub-id pub-id-type="pmid">17316991</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><name><surname>Miguel-Hidalgo</surname><given-names>JJ</given-names></name><name><surname>Waltzer</surname><given-names>R</given-names></name><name><surname>Whittom</surname><given-names>AA</given-names></name><name><surname>Austin</surname><given-names>MC</given-names></name><name><surname>Rajkowska</surname><given-names>G</given-names></name><name><surname>Stockmeier</surname><given-names>CA</given-names></name><article-title>Glial and glutamatergic markers in depression, alcoholism, and their comorbidity</article-title><source>J Affect Disord</source><year>2010</year><volume>127</volume><fpage>230</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2010.06.003</pub-id><?supplied-pmid 20580095?><pub-id pub-id-type="pmid">20580095</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><name><surname>Toro</surname><given-names>CT</given-names></name><name><surname>Hallak</surname><given-names>JE</given-names></name><name><surname>Dunham</surname><given-names>JS</given-names></name><name><surname>Deakin</surname><given-names>JF</given-names></name><article-title>Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder</article-title><source>Neurosci Lett</source><year>2006</year><volume>404</volume><fpage>276</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2006.05.067</pub-id><?supplied-pmid 16842914?><pub-id pub-id-type="pmid">16842914</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Vadakkan</surname><given-names>KI</given-names></name><name><surname>Kim</surname><given-names>SS</given-names></name><name><surname>Wu</surname><given-names>LJ</given-names></name><name><surname>Shang</surname><given-names>Y</given-names></name><name><surname>Zhuo</surname><given-names>M</given-names></name><article-title>Selective activation of microglia in spinal cord but not higher cortical regions following nerve injury in adult mouse</article-title><source>Mol Pain</source><year>2008</year><volume>4</volume><fpage>15</fpage><pub-id pub-id-type="doi">10.1186/1744-8069-4-15</pub-id><?supplied-pmid 18423014?><pub-id pub-id-type="pmid">18423014</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><name><surname>Svensson</surname><given-names>CI</given-names></name><name><surname>Brodin</surname><given-names>E</given-names></name><article-title>Spinal astrocytes in pain processing: non-neuronal cells as therapeutic targets</article-title><source>Mol Interv</source><year>2010</year><volume>10</volume><fpage>25</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1124/mi.10.1.6</pub-id><?supplied-pmid 20124561?><pub-id pub-id-type="pmid">20124561</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><name><surname>Decosterd</surname><given-names>I</given-names></name><name><surname>Woolf</surname><given-names>CJ</given-names></name><article-title>Spared nerve injury: an animal model of persistent peripheral neuropathic pain</article-title><source>Pain</source><year>2000</year><volume>87</volume><fpage>149</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1016/S0304-3959(00)00276-1</pub-id><?supplied-pmid 10924808?><pub-id pub-id-type="pmid">10924808</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><name><surname>Bourquin</surname><given-names>AF</given-names></name><name><surname>Suveges</surname><given-names>M</given-names></name><name><surname>Pertin</surname><given-names>M</given-names></name><name><surname>Gilliard</surname><given-names>N</given-names></name><name><surname>Sardy</surname><given-names>S</given-names></name><name><surname>Davison</surname><given-names>AC</given-names></name><name><surname>Spahn</surname><given-names>DR</given-names></name><article-title>Decosterd I: <bold>Assessment and analysis of mechanical allodynia-like behavior induced by spared nerve injury (SNI) in the mouse</bold></article-title><source>Pain</source><year>2006</year><volume>122</volume><issue>14</issue><fpage>e11</fpage><lpage>14</lpage></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><name><surname>Chaplan</surname><given-names>SR</given-names></name><name><surname>Bach</surname><given-names>FW</given-names></name><name><surname>Pogrel</surname><given-names>JW</given-names></name><name><surname>Chung</surname><given-names>JM</given-names></name><name><surname>Yaksh</surname><given-names>TL</given-names></name><article-title>Quantitative assessment of tactile allodynia in the rat paw</article-title><source>J Neurosci Methods</source><year>1994</year><volume>53</volume><fpage>55</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/0165-0270(94)90144-9</pub-id><?supplied-pmid 7990513?><pub-id pub-id-type="pmid">7990513</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><name><surname>Choi</surname><given-names>Y</given-names></name><name><surname>Yoon</surname><given-names>YW</given-names></name><name><surname>Na</surname><given-names>HS</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Chung</surname><given-names>JM</given-names></name><article-title>Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain</article-title><source>Pain</source><year>1994</year><volume>59</volume><fpage>369</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1016/0304-3959(94)90023-X</pub-id><?supplied-pmid 7708411?><pub-id pub-id-type="pmid">7708411</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><name><surname>Jones</surname><given-names>BJ</given-names></name><name><surname>Roberts</surname><given-names>DJ</given-names></name><article-title>The quantiative measurement of motor inco-ordination in naive mice using an acelerating rotarod</article-title><source>J Pharm Pharmacol</source><year>1968</year><volume>20</volume><fpage>302</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1111/j.2042-7158.1968.tb09743.x</pub-id><?supplied-pmid 4384609?><pub-id pub-id-type="pmid">4384609</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="book"><name><surname>Paxinos</surname><given-names>G</given-names></name><name><surname>Franklin</surname><given-names>K</given-names></name><source>The mouse brain in stereotaxic coordinates</source><year>2004</year><publisher-name>Waltham Massachusetts: Academic Press</publisher-name></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><name><surname>Wrobel</surname><given-names>GKF</given-names></name><article-title>Lichter: <bold>Autoprime: Selecting primers for expressed sequences</bold></article-title><source>Genome Biol</source><year>2004</year><volume>5</volume><fpage>11</fpage></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Pachter</surname><given-names>L</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name><article-title>TopHat: discovering splice junctions with RNA-Seq</article-title><source>Bioinformatics</source><year>2009</year><volume>25</volume><fpage>1105</fpage><lpage>1111</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp120</pub-id><?supplied-pmid 19289445?><pub-id pub-id-type="pmid">19289445</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><name><surname>Gentleman</surname><given-names>RC</given-names></name><name><surname>Carey</surname><given-names>VJ</given-names></name><name><surname>Bates</surname><given-names>DM</given-names></name><name><surname>Bolstad</surname><given-names>B</given-names></name><name><surname>Dettling</surname><given-names>M</given-names></name><name><surname>Dudoit</surname><given-names>S</given-names></name><name><surname>Ellis</surname><given-names>B</given-names></name><name><surname>Gautier</surname><given-names>L</given-names></name><name><surname>Ge</surname><given-names>Y</given-names></name><name><surname>Gentry</surname><given-names>J</given-names></name><article-title>Bioconductor: open software development for computational biology and bioinformatics</article-title><source>Genome Biol</source><year>2004</year><volume>5</volume><fpage>R80</fpage><pub-id pub-id-type="doi">10.1186/gb-2004-5-10-r80</pub-id><?supplied-pmid 15461798?><pub-id pub-id-type="pmid">15461798</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><name><surname>Anders</surname><given-names>S</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><article-title>Differential expression analysis for sequence count data</article-title><source>Genome Biol</source><year>2010</year><volume>11</volume><fpage>R106</fpage><pub-id pub-id-type="doi">10.1186/gb-2010-11-10-r106</pub-id><?supplied-pmid 20979621?><pub-id pub-id-type="pmid">20979621</pub-id></mixed-citation></ref></ref-list></back></article>